Kimberly-Clark (KMB) 10-K9 Feb 232022 FY Annual reportFinancial data

Company Profile

Audit Information

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2022
Audit Information [Abstract]
Auditor Firm ID	34
Auditor Location	Dallas, Texas
Auditor Name	Deloitte & Touche LLP

Cover Page Cover Page

Cover Page Cover Page - USD ($) $ in Billions	12 Months Ended
Cover Page Cover Page - USD ($) $ in Billions	Dec. 31, 2022	Jan. 31, 2023	Jun. 30, 2022
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	1-225
Entity Registrant Name	KIMBERLY-CLARK CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	39-0394230
Entity Address, Address Line One	P.O. Box 619100
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75261-9100
City Area Code	972
Local Phone Number	281-1200
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 45.6
Entity Common Stock, Shares Outstanding		337,507,349
Documents Incorporated by Reference	Certain information contained in the definitive Proxy Statement for Kimberly-Clark's Annual Meeting of Stockholders to be held on April 20, 2023 is incorporated by reference into Part III.
Auditor Name	Deloitte & Touche LLP
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0000055785
ICFR Auditor Attestation Flag	true
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock-$1.25 par value
Trading Symbol	KMB
Security Exchange Name	NYSE
0.625% Notes Due 2024
Document Information [Line Items]
Title of 12(b) Security	0.625% Notes due 2024
Trading Symbol	KMB24
Security Exchange Name	NYSE

Consolidated Income Statement

Consolidated Income Statement - USD ($) $ in Millions		12 Months Ended
Consolidated Income Statement - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net Sales	[1]	$ 20,175	$ 19,440	$ 19,140
Cost of products sold		13,956	13,452	12,318
Gross Profit		6,219	5,988	6,822
Marketing, research and general expenses		3,581	3,399	3,632
Other (income) and expense, net	[2]	(43)	28	(54)
Operating Profit		2,681	2,561	3,244
Nonoperating expense		(73)	(86)	(70)
Interest income		14	6	8
Interest expense		(282)	(256)	(252)
Income Before Income Taxes and Equity Interests		2,340	2,225	2,930
Provision for income taxes		(495)	(479)	(676)
Income Before Equity Interests		1,845	1,746	2,254
Share of net income of equity companies		116	98	142
Net income		1,961	1,844	2,396
Net income attributable to noncontrolling interests		(27)	(30)	(44)
Net Income Attributable to Kimberly-Clark Corporation		$ 1,934	$ 1,814	$ 2,352
Earnings Per Share [Abstract]
Basic		$ 5.73	$ 5.38	$ 6.90
Diluted		$ 5.72	$ 5.35	$ 6.87

[1] Net sales in the U.S. to third parties totaled $9,848, $9,285 and $9,679 in 2022, 2021 and 2020, respectively. No other individual country's net sales exceeds 10 percent of total net sales.

Consolidated Statement of Compr

Consolidated Statement of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 1,961	$ 1,844	$ 2,396
Other Comprehensive Income (Loss), Net of Tax
Unrealized currency translation adjustments	(355)	(288)	129
Employee postretirement benefits	103	122	37
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(185)	84	(34)
Total Other Comprehensive Income (Loss), Net of Tax	(437)	(82)	132
Comprehensive Income	1,524	1,762	2,528
Comprehensive income attributable to noncontrolling interests	(19)	(15)	(55)
Comprehensive Income Attributable to Kimberly-Clark Corporation	$ 1,505	$ 1,747	$ 2,473

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
Current Assets
Cash and cash equivalents		$ 427	$ 270
Accounts receivable, net		2,280	2,207
Inventories		2,269	2,239
Other current assets		753	849
Total Current Assets		5,729	5,565
Property, Plant and Equipment, Net		7,885	8,097
Investments in Equity Companies		238	290
Goodwill	[1]	2,074	1,840
Intangible Assets, Net (Excluding Goodwill)		851	810
Other Assets		1,193	1,235
TOTAL ASSETS		17,970	17,837
Current Liabilities
Debt payable within one year		844	433
Trade accounts payable		3,813	3,840
Accrued expenses and other current liabilities		2,289	2,096
Dividends payable		388	380
Total Current Liabilities		7,334	6,749
Long-Term Debt		7,578	8,141
Noncurrent Employee Benefits		654	809
Deferred Income Tax Liabilities, Net		647	694
Other Liabilities		799	681
Redeemable Common and Preferred Securities of Subsidiaries		$ 258	$ 26
Preferred stock, shares issued		0	0
Preferred stock, shares authorized		20,000,000	20,000,000
Preferred stock, par value per share		$ 0	$ 0
Common stock, shares authorized		1,200,000,000	1,200,000,000
Common stock, shares issued		378,600,000	378,600,000
Common stock, par value per share		$ 1.25	$ 1.25
Stockholders' Equity
Preferred stock - no par value - authorized 20.0 million shares, none issued		$ 0	$ 0
Common stock - $1.25 par value - authorized 1.2 billion shares; issued 378.6 million shares at December 31, 2022 and 2021		473	473
Additional paid-in capital		$ 679	$ 605
Common stock held in treasury, shares		41,100,000	41,800,000
Common stock held in treasury, at cost - 41.1 and 41.8 million shares at December 31, 2022 and 2021, respectively		$ (5,137)	$ (5,183)
Retained earnings		8,201	7,858
Accumulated other comprehensive income (loss)		(3,669)	(3,239)
Total Kimberly-Clark Corporation Stockholders' Equity		547	514
Noncontrolling Interests		153	223
Total Stockholders' Equity		700	737
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		$ 17,970	$ 17,837

[1]Stockholders' Equity The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2020 $ (2,157) $ (912) $ (40) $ (63) Other comprehensive income (loss) before reclassifications (265) 37 9 53 (Income) loss reclassified from AOCI — 72 (a) (3) (a) 30 Net current period other comprehensive income (loss) (265) 109 6 83 Balance as of December 31, 2021 (2,422) (803) (34) 20 Other comprehensive income (loss) before reclassifications (347) (51) 86 (139) (Income) loss reclassified from AOCI — 65 (a) — (a) (44) Net current period other comprehensive income (loss) (347) 14 86 (183) Balance as of December 31, 2022 $ (2,769) $ (789) $ 52 $ (163) (a) Included in computation of net periodic pension and other postretirement benefits costs (see Note 8). Included in the above defined benefit pension plans and other postretirement benefit plans balances as of December 31, 2022 is $735 and $2 of unrecognized net actuarial loss and unrecognized net prior service credit, respectively. The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2022 2021 2020 Unrealized translation $ (324) $ (248) $ 98 Tax effect (23) (17) 16 (347) (265) 114 Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (109) 16 24 Amortization 34 37 41 Settlements and curtailments 52 91 49 Currency and other 36 10 (26) 13 154 88 Unrecognized prior service cost/credit Funded status recognition 2 (2) 2 Amortization — (4) (4) Curtailments — (3) — Currency and other — — 1 2 (9) (1) Tax effect (1) (36) (20) 14 109 67 Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other 113 12 (35) Tax effect (27) (6) 8 86 6 (27) Cash flow hedges and other Recognition of effective portion of hedges (165) 70 (32) Amortization (58) 39 (2) Currency and other (22) (4) (5) Tax effect 62 (22) 7 (183) 83 (32) Change in AOCI $ (430) $ (67) $ 122 Amounts are reclassified from AOCI into Cost of products sold, Nonoperating expense, Interest expense, or Other (income) and expense, net, as applicable, in the consolidated income statement. Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in AOCI. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. The change in unrealized translation in 2022 is primarily due to the weakening of various foreign currencies versus the U.S. dollar, particularly the Indonesian rupiah and the British pound. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parenthetical) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 0	$ 0
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 1.25	$ 1.25
Common stock, shares authorized	1,200,000,000	1,200,000,000
Common stock, shares issued	378,600,000	378,600,000
Common stock held in treasury, shares	41,100,000	41,800,000

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Common Stock Issued	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Non- controlling Interests
Stockholders' Equity, Attributable to Noncontrolling Interest							$ 227
Increase (Decrease) in Stockholders' Equity
Shares, Issued		378,597
Common Stock, Value, Issued at Dec. 31, 2019		$ 473
Additional Paid in Capital at Dec. 31, 2019			$ 556
Treasury Stock, Value at Dec. 31, 2019				$ (4,454)
Retained Earnings at Dec. 31, 2019					$ 6,686
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance at Dec. 31, 2019						$ (3,294)
Beginning Balance at Dec. 31, 2019	$ 194
Beginning Balance, treasury stock (in shares) at Dec. 31, 2019				37,149
Increase (Decrease) in Stockholders' Equity
Net income in stockholders' equity, excludes redeemable interests' share	2,396				2,352
Net Income (Loss) Attributable to Noncontrolling Interest	44						41
Other comprehensive income, net of tax, attributable to parent	2,473					121
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share	2,393
Other comprehensive income, net of tax, attributable to noncontrolling interest	(55)						12
Other Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Non Contolling Interest, Excludes Redeemable Interests' Share	133
Stock-based awards exercised or vested	216		(55)	$ 271
Stock-based awards exercised or vested (in shares)				(2,339)
Shares repurchased (in shares)				5,063
Shares repurchased				$ (716)
Recognition of stock-based compensation	$ 142		142
Dividends declared					(1,458)
Dividends declared per share	$ 4.28
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders							(36)
Dividends, Common Stock, Cash and Decrease from Distributions to Noncontrolling Interest Holders	$ 1,494
Other	1		(14)		13	(1)	1
Ending Balance at Dec. 31, 2020	869
Common Stock, Value, Issued at Dec. 31, 2020		$ 473
Additional Paid in Capital at Dec. 31, 2020			657
Treasury Stock, Value at Dec. 31, 2020				$ (4,899)
Treasury stock (in shares) at Dec. 31, 2020				39,873
Retained Earnings at Dec. 31, 2020					7,567
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance at Dec. 31, 2020						(3,172)
Stockholders' Equity, Attributable to Noncontrolling Interest							243
Increase (Decrease) in Stockholders' Equity
Common stock, shares, Issued		378,597
Net income in stockholders' equity, excludes redeemable interests' share	1,844				1,814
Net Income (Loss) Attributable to Noncontrolling Interest	30						29
Other comprehensive income, net of tax, attributable to parent	1,747					(67)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share	1,843
Other comprehensive income, net of tax, attributable to noncontrolling interest	(15)						(14)
Other Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Non Contolling Interest, Excludes Redeemable Interests' Share	(81)
Stock-based awards exercised or vested	66		(80)	$ 146
Stock-based awards exercised or vested (in shares)				(1,339)
Shares repurchased (in shares)				3,228
Shares repurchased				$ (430)
Recognition of stock-based compensation	$ 26		26
Dividends declared					(1,538)
Dividends declared per share	$ 4.56
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders							(36)
Dividends, Common Stock, Cash and Decrease from Distributions to Noncontrolling Interest Holders	$ (1,574)
Other	18		(2)		(15)		(1)
Ending Balance at Dec. 31, 2021	737
Common Stock, Value, Issued at Dec. 31, 2021	473	$ 473
Additional Paid in Capital at Dec. 31, 2021	605		605
Treasury Stock, Value at Dec. 31, 2021	$ (5,183)			$ (5,183)
Treasury stock (in shares) at Dec. 31, 2021	41,800			41,762
Retained Earnings at Dec. 31, 2021	$ 7,858				7,858
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance at Dec. 31, 2021	$ (3,239)					(3,239)
Stockholders' Equity, Attributable to Noncontrolling Interest							223
Increase (Decrease) in Stockholders' Equity
Common stock, shares, Issued	378,600	378,597
Net income in stockholders' equity, excludes redeemable interests' share	$ 1,961				1,934
Net Income (Loss) Attributable to Noncontrolling Interest	27						38
Other comprehensive income, net of tax, attributable to parent	1,505					(429)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share	1,972
Other comprehensive income, net of tax, attributable to noncontrolling interest	(19)						(9)
Other Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Non Contolling Interest, Excludes Redeemable Interests' Share	(438)
Stock-based awards exercised or vested	59		(86)	$ 145
Stock-based awards exercised or vested (in shares)				(1,406)
Shares repurchased (in shares)				779
Shares repurchased				$ (100)
Recognition of stock-based compensation	$ 147		147
Dividends declared					(1,566)
Dividends declared per share	$ 4.64
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders							(98)
Dividends, Common Stock, Cash and Decrease from Distributions to Noncontrolling Interest Holders	$ (1,664)
Other	(13)		(13)	1	25	(1)	1
Ending Balance at Dec. 31, 2022	700
Common Stock, Value, Issued at Dec. 31, 2022	473	$ 473
Additional Paid in Capital at Dec. 31, 2022	679		$ 679
Treasury Stock, Value at Dec. 31, 2022	$ (5,137)			$ (5,137)
Treasury stock (in shares) at Dec. 31, 2022	41,100			41,135
Retained Earnings at Dec. 31, 2022	$ 8,201				$ 8,201
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance at Dec. 31, 2022	$ (3,669)					$ (3,669)
Stockholders' Equity, Attributable to Noncontrolling Interest							$ 153
Increase (Decrease) in Stockholders' Equity
Common stock, shares, Issued	378,600	378,597

Consolidated Cash Flow Statemen

Consolidated Cash Flow Statement - USD ($) $ in Millions	12 Months Ended
Consolidated Cash Flow Statement - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Activities
Net income	$ 1,961	$ 1,844	$ 2,396
Depreciation and amortization	754	766	796
Asset Impairments	0	3	17
Stock-based compensation	150	26	147
Deferred income taxes	(57)	(70)	45
Net (gains) losses on asset dispositions	15	39	68
Equity companies' earnings (in excess of) less than dividends paid	6	25	(30)
Operating working capital	(17)	46	363
Postretirement benefits	(4)	47	(28)
Other	10	4	(45)
Cash Provided by Operations	2,733	2,730	3,729
Investing Activities
Capital spending	(876)	(1,007)	(1,217)
Payments to Acquire Businesses, Net of Cash Acquired	(46)	0	(1,083)
Proceeds from dispositions of property	12	43	31
Investments in time deposits	(658)	(918)	(753)
Maturities of time deposits	797	836	690
Other	(14)	(10)	27
Cash Used for Investing	(785)	(1,056)	(2,305)
Financing Activities
Cash dividends paid	(1,558)	(1,516)	(1,451)
Change in short-term debt	261	(97)	(561)
Debt proceeds	0	605	1,845
Debt repayments	(312)	(269)	(854)
Proceeds from exercise of stock options	94	65	217
Acquisitions of common stock for the treasury	(100)	(400)	(700)
Other	(47)	(48)	(26)
Cash Used for Financing	(1,760)	(1,696)	(1,567)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(31)	(11)	4
Change in Cash and Cash Equivalents	157	(33)	(139)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	427	270	303
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain	(85)	0	0
Payments of Ordinary Dividends, Noncontrolling Interest	$ (98)	$ (36)	$ (37)

Accounting Policies

Accounting Policies	12 Months Ended
Accounting Policies	Dec. 31, 2022
Accounting Policies [Abstract]
Accounting Policies	Accounting Policies Basis of Presentation The consolidated financial statements present the accounts of Kimberly-Clark Corporation and all subsidiaries in which it has a controlling financial interest as if they were a single economic entity in conformity with accounting principles generally accepted in the United States of America ("GAAP"). All intercompany transactions and accounts are eliminated in consolidation. The terms "Corporation," "Kimberly-Clark," "we," "our," and "us" refer to Kimberly-Clark Corporation and all subsidiaries in which it has a controlling financial interest. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted. Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Actual results could differ from these estimates, and changes in these estimates are recorded when known. Estimates are used in accounting for, among other things, sales incentives and trade promotion allowances, employee postretirement benefits, and deferred income taxes and potential assessments. Cash Equivalents Cash equivalents are short-term investments with an original maturity date of three months or less. Inventories and Distribution Costs Most U.S. inventories are valued at the lower of cost, using the Last-In, First-Out ("LIFO") method, or market. The balance of the U.S. inventories and inventories of consolidated operations outside the U.S. are valued at the lower of cost or net realizable value using either the First-In, First-Out ("FIFO") or weighted-average cost methods. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Distribution costs are classified as cost of products sold. Property and Depreciation Property, plant and equipment are stated at cost and are depreciated on the straight-line method. Buildings are depreciated over their estimated useful lives, primarily 40 years. Machinery and equipment are depreciated over their estimated useful lives, primarily ranging from 16 to 20 years. Purchases of computer software, including external costs and certain internal costs (including payroll and payroll-related costs of employees) directly associated with developing significant computer software applications for internal use, are capitalized. Computer software costs are amortized on the straight-line method over the estimated useful life of the software, which generally does not exceed 5 years. Estimated useful lives are periodically reviewed and, when warranted, changes are made to them. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. An impairment loss would be indicated when estimated undiscounted future cash flows from the use and eventual disposition of an asset group, which are identifiable and largely independent of the cash flows of other asset groups, are less than the carrying amount of the asset group. Measurement of an impairment loss would be based on the excess of the carrying amount of the asset group over its fair value. Fair value is measured using discounted cash flows or independent appraisals, as appropriate. When property is sold or retired, the cost of the property and the related accumulated depreciation are removed from the consolidated balance sheet and any gain or loss on the transaction is included in income. Goodwill and Other Intangible Assets Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses. Goodwill is not amortized, but rather is assessed for impairment annually and whenever events and circumstances indicate that impairment may have occurred. Impairment testing compares the reporting unit carrying amount, including goodwill, with its fair value. If the reporting unit carrying amount, including goodwill, exceeds its fair value, a goodwill impairment charge for the excess amount above fair value would be recorded. In our evaluation of goodwill impairment, we have the option to first assess qualitative factors such as macroeconomic, industry and competitive conditions, legal and regulatory environments, historical and projected financial performance, significant changes in the reporting unit and the magnitude of excess fair value over carrying amount from the previous quantitative impairment testing. If the qualitative assessment determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then a quantitative impairment test using discounted cash flows to estimate fair value must be performed. Alternatively, if the qualitative assessment determines that it is more likely than not that the fair value of a reporting unit is more than its carrying value, then further quantitative testing is not required. For 2022, we completed the required annual assessment of goodwill for impairment for all of our reporting units using a qualitative assessment as of the first day of the third quarter, and we determined that it is more likely than not that the fair value of goodwill significantly exceeds the carrying amount for each of our reporting units. Indefinite-lived intangible assets, other than goodwill, consist of certain brand names related to our acquisition of Softex Indonesia and are tested for impairment annually at the same time as our goodwill impairment assessment and whenever events and circumstances indicate that impairment may have occurred. Our estimate of the fair value of our brand assets is based on a discounted cash flow model and a market-based approach using inputs which include projected revenues from our long-range plan, assumed royalty rates that could be payable if we did not own the brands, and a discount rate. For 2022, we completed the required annual assessment of indefinite-lived intangible assets, other than goodwill, for impairment using a qualitative assessment as of the first day of the third quarter, and we determined that it is more likely than not that the fair value is more than the carrying amount for each of these intangible assets. Intangible assets with finite lives are amortized over their estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. An impairment loss would be indicated when estimated undiscounted future cash flows from the use of the asset are less than its carrying amount. An impairment loss would be measured as the difference between the fair value (based on discounted future cash flows) and the carrying amount of the asset. Estimated useful lives range from 10 to 20 years for trademarks and 4 to 20 years for certain acquired distributor and customer relationships. Investments in Equity Companies Investments in companies which we do not control but over which we have the ability to exercise significant influence and that, in general, are at least 20 percent-owned by us, are stated at cost plus equity in undistributed net income. These investments are evaluated for impairment when warranted. An impairment loss would be recorded whenever a decline in value of an equity investment below its carrying amount is determined to be other than temporary. In judging "other than temporary," we would consider the length of time and extent to which the fair value of the equity company investment has been less than the carrying amount, the near-term and longer-term operating and financial prospects of the equity company, and our longer-term intent of retaining the investment in the equity company. Revenue Recognition Sales revenue is recognized at the time of product shipment or delivery, depending on when control passes, to unaffiliated customers, and when all of the following have occurred: a firm sales agreement is in place, pricing is fixed or determinable, and collection is reasonably assured. Sales are reported net of returns, consumer and trade promotions, rebates and freight allowed. Taxes imposed by governmental authorities on our revenue-producing activities with customers, such as sales taxes and value-added taxes, are excluded from net sales. Sales Incentives and Trade Promotion Allowances The cost of promotion activities provided to customers is classified as a reduction in sales revenue. In addition, the estimated redemption value of consumer coupons and related expense are recorded when the related revenue from customers is realized. Rebate and promotion accruals are based on estimates of the quantity of customer sales. Promotion accruals also consider estimates of the number of consumer coupons that will be redeemed and timing and costs of activities within the promotional programs. Advertising Expense Advertising costs are expensed in the year the related advertisement or campaign is first presented through traditional or digital media. For interim reporting purposes, advertising expenses are charged to operations as a percentage of sales based on estimated sales and related advertising expense for the full year. Research Expense Research and development costs are charged to expense as incurred. Other Income Certain amounts not directly associated with the current operations of the business are recorded in Other (income) and expense, net. In the first quarter of 2022, an $85 non-recurring, non-cash gain was recognized in Other (income) expense, net as a result of the remeasurement of the carrying value of our previously held equity investment to fair value upon the acquisition of a controlling interest in Thinx Inc. ("Thinx"). See Note 3 for details on the acquisition of Thinx. In the fourth quarter of 2020, we received a favorable legal ruling that resolved certain matters related to prior years’ business taxes in Brazil. These matters involved the revenue base, which included value added taxes, used to calculate and pay social security taxes for the period 2004 to 2014. In the legal ruling, the São Paulo State Court recognized our right to exclude the value added taxes from the revenue base used to calculate those social security taxes. This decision resulted in business tax credits being recognized of $77. Foreign Currency Translation The income statements of foreign operations, other than those in highly inflationary economies, are translated into U.S. dollars at rates of exchange in effect each month. The balance sheets of these operations are translated at period-end exchange rates, and the differences from historical exchange rates are reflected in stockholders' equity as unrealized translation adjustments. Under highly inflationary accounting, the countries' functional currency becomes the U.S. dollar, and its income statement and balance sheet are measured in U.S. dollar using both current and historical rates of exchange. As of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiaries in Argentina (“K-C Argentina”). The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material . As of December 31, 2022, K-C Argentina had a small net peso monetary position. Net sales of K-C Argentina were approximate ly 1 percent of o ur consolidated net sales in 2022, 2021 and 2020. As of April 1, 2022, we elected to adopt highly inflationary accounting for our subsidiary in Turkey (“K-C Turkey”). The effect of changes in exchange rates on lira-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material. As of December 31, 2022, K-C Turkey had a small net lira monetary position. Net sales of K-C Turkey were less than 1 percent of our consolidated net sales. Derivative Instruments and Hedging Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments, interest rate swaps and locks, and the majority of commodity hedging contracts are entered into with major financial institutions. At inception, we formally designate certain derivatives as cash flow, fair value or net investment hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions or financial balances they are hedging. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings as they occur. All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The gain or loss on derivatives designated as fair value hedges and the offsetting loss or gain on the hedged item attributable to the hedged risk are included in income in the period that changes in fair value occur. The gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. The gain or loss on derivatives designated as hedges of investments in foreign subsidiaries is recognized in other comprehensive income to offset the change in value of the net investments being hedged. Certain foreign-currency derivative instruments not designated as hedging instruments have been entered into to manage certain non-functional currency denominated monetary assets and liabilities. The gain or loss on these derivatives is included in income in the period that changes in their fair values occur. Cash flows from derivatives are classified within the consolidated statement of cash flows in the same category as the items being hedged. Cash flows from derivatives are classified within Operating Activities, except for derivatives designated as net investment hedges which are classified in Investing Activities. See Note 12 for disclosures about derivative instruments and hedging activities. Leases Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and exclude lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. Variable lease payments are generally expensed as incurred and include certain index-based changes in rent, certain nonlease components, such as maintenance and other services provided by the lessor, and other charges included in the lease. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term. Certain lease agreements with lease and nonlease components are combined as a single lease component. The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Accounting Standard Issued - Not Adopted as of December 31, 2022 In 2022, the Financial Accounting Standards Board issued Accounting Standard Update (“ASU”) No. 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-50) . The new guidance requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. We adopted this ASU as of January 1, 2023 on a prospective basis. As the guidance requires only additional disclosures, the effects of this standard on our financial position, results of operations and cash flows were not material.

2018 Global Restructuring Progr

2018 Global Restructuring Program	12 Months Ended
2018 Global Restructuring Program	Dec. 31, 2022
2018 Global Restructuring Program
Restructuring Cost and Reserve
Restructuring and Related Activities Disclosure	2018 Global Restructuring Program In 2018, we initiated our 2018 Global Restructuring Program to reduce our structural cost base by streamlining and simplifying our manufacturing supply chain and overhead organization. The restructuring actions were completed in 2021. We closed or sold 11 manufacturing facilities and expanded production capacity at several others. We exited or divested some lower-margin businesses that generated approximately 1 percent of our net sales. Workforce reductions were approximately 6,000. The restructuring impacted all of our business segments and our organizations in all major geographies. The restructuring actions were completed with total costs of $2.2 billion pre-tax ($1.6 billion after tax). Pre-tax cash and non-cash costs of $1.2 billion and $1.0 billion, respectively, were incurred. The following net charges were incurred in connection with the 2018 Global Restructuring Program: Year Ended December 31 2021 2020 2019 2018 Total Cost of products sold: Charges for workforce reductions $ 4 $ 10 $ 31 $ 149 $ 194 Asset impairments 3 17 — 74 94 Asset write-offs 17 63 54 112 246 Incremental depreciation 18 94 235 172 519 Other exit costs 112 99 96 34 341 Total 154 283 416 541 1,394 Marketing, research and general expenses: Charges for workforce reductions 39 13 (12) 243 283 Other exit costs 72 96 111 137 416 Total 111 109 99 380 699 Other (income) and expense, net (a) 10 (9) (194) (12) (205) Nonoperating expense (b) 79 36 45 127 287 Total charges 354 419 366 1,036 2,175 Provision for income taxes (75) (94) (118) (243) (530) Net charges 279 325 248 793 1,645 Net impact related to equity companies and 2 (2) — (10) (10) Net charges attributable to Kimberly-Clark $ 281 $ 323 $ 248 $ 783 $ 1,635 (a) Other (income) and expense, net in 2019 was the result of pre-tax gains on the sales of manufacturing facilities and associated real estate which were disposed of as part of the restructuring. (b) Represents non-cash pension settlement and curtailment charges resulting from restructuring actions, primarily in the U.S., United Kingdom and Canada. The measurement of the asset impairment charges was based on the excess of the carrying values of the impacted asset groups over their fair values. These fair values were measured by using discounted cash flows expected over the limited time the assets would remain in use or the expected sales value, and as a result, the assets were essentially written off or written down to fair value less costs to sell. The use of discounted cash flows represents a level 3 measure under the fair value hierarchy. The following summarizes the restructuring liabilities activity: 2021 Restructuring liabilities at January 1 $ 93 Charges for workforce reductions and other cash exit costs 222 Cash payments (235) Currency and other (2) Restructuring liabilities at December 31 $ 78 As of December 31, 2022, remaining restructuring liabilities were not material. As of December 31, 2021, restructuring liabilities of $75 were recorded in Accrued expenses and other current liabilities and $3 were recorded in Other Liabilities. The impact related to restructuring charges was recorded in Operating working capital and Other Operating Activities, as appropriate, in our consolidated cash flow statement. Cash payments of $249, $302 and $325 were made during 2020, 2019 and 2018, respectively.

Acquisition

Acquisition	12 Months Ended
Acquisition	Dec. 31, 2022
Business Combinations [Abstract]
Mergers, Acquisitions and Dispositions Disclosures	Acquisitions 2022 Thinx Acquisition On February 24, 2022, we completed our acquisition of a majority and controlling share of Thinx, an industry leader in the reusable period and incontinence underwear category, for total consideration of $181 consisting of cash of $53 , the fair value of our previously held equity investment of $127, and certain share-based award costs of $1. We previously accounted for our ownership interest in Thinx as an equity method investment, but upon increasing our ownership to 58%, w e began consolidating the operations of Thinx into our financial statements at the end of the first quarter of 2022. The consolidated results of operations for Thinx are reported in our Personal Care business segment on a one-month lag. The share of Thinx net income and equity attributable to the third-party minority owner of Thinx is classified in our consolidated income statement within Net income attributable to noncontrolling interests and in our consolidated balance sheet within Redeemable Common and Preferred Securities of Subsidiaries. This noncontrolling equity interest is measured at the estimated redemption value, which approximates fair value. We have substantially completed an initial purchase price allocation in which we utilized several generally accepted valuation methodologies to estimate the fair value of certain acquired assets. The primary valuation methods included two forms of the Income Approach (i.e., the multi-period excess earnings method [distributor method] and the relief-from-royalty method). These valuation methodologies are commonly used to value similar identifiable intangible assets in the Consumer Packaged Goods industry. All of the selected valuation methodologies incorporate unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy in Accounting Standard Codification 820, Fair Value Measurements . In connection with these valuation methodologies, we are required to make estimates and assumptions regarding market comparable companies, revenue growth rates, operating margins, distributor and customer attrition rates, royalty rates, distributor margins, discount rates, etc., which are primarily based on cash flow forecasts, business plans, economic projections and other information available to market participants. The total purchase price consideration was allocated to the net assets acquired based upon their respective estimated fair values as follows: Current assets $ 28 Property, Plant and Equipment, Net 2 Goodwill 297 Other Intangible Assets, Net 123 Other assets 4 Current liabilities (17) Deferred income taxes (18) Other liabilities (4) Fair value of net assets acquired 415 Less fair value of noncontrolling interest (234) Total purchase price consideration $ 181 Other Intangible Assets, Net includes brands and customer relationships which have estimated useful lives of 4 to 15 years, primarily 15 years. Based on the carrying value of these finite-lived assets as of December 31, 2022, amortization expense per year for each of the next five years is estimated to be approximately $8. Goodwill of $297 w as allocated to the Personal Care business segment. The goodwill is primarily attributable to future growth opportunities and any intangible assets that did not qualify for separate recognition. For tax purposes, the acquisition of additional Thinx shares was treated as a stock acquisition, and the goodwill acquired is not tax deductible. The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above. We continue to evaluate potential contingencies that may have existed as of the acquisition date and expect to finalize the purchase price allocation no later than the first quarter of 2023. As a result of this transaction during the quarter ended March 31, 2022, an $85 non-recurring, non-cash gain was recognized in Other (income) expense, net as a result of the remeasurement of the carrying value of our previously held equity investment to fair value, and related transaction and integration costs of $21 were recorded in Marketing, research and general expenses. This recognition resulted in a net benefit of $64 pre-tax ($68 after tax) being included in our consolidated income statement for the quarter ended March 31, 2022. In addition, we removed the non-cash gain impact from Operating Activities in our consolidated cash flow statements for the year ended December 31, 2022. Pro forma results of operations have not been presented as the impact on our consolidated financial statements is not material. 2020 Softex Indonesia Acquisition On October 1, 2020 (“Acquisition Date”), we acquired Softex Indonesia, a leader in the fast-growing Indonesian personal care market, in an all-cash transaction for approximately $1.2 billion. This transaction significantly expands our presence in an important developing and emerging market and is a strong strategic fit with our core business. The transaction price, subject to working capital and net debt adjustments, resulted in a final purchase price of $1.1 billion in addition to the assumption of certain indebtedness of Softex Indonesia at closing. During the year ended December 31, 2020, we recorded transaction and integration costs of $32 in Marketing, research and general expenses. During the fourth quarter of 2020, we substantially completed and recorded an initial purchase price allocation, in which we utilized several generally accepted valuation methodologies to determine the fair value of certain acquired assets. The primary valuation methods included the replacement cost approach, sales comparison approach, discounted cash flow, multi-period excess earnings, relief from royalty and distributor methods. The purchase price allocation was finalized by October 2021 and included an immaterial amount of recorded measurement period adjustments. The measurement period adjustments to the initial allocation were based on more detailed information obtained about the specific assets acquired and liabilities assumed as of the Acquisition Date. Goodwill of $404 was allocated to the Personal Care business segment. The goodwill is primarily attributable to future growth opportunities and any intangible assets that did not qualify for separate recognition. While the goodwill is not deductible for local tax purposes, it is treated as an amortizable expense for the U.S. global intangible low-taxed income ("GILTI") c omputation. The consolidated results of operations for Softex Indonesia are reported primarily in our Personal Care business segment on a one-month lag.

Intangible Assets, Goodwill and

Intangible Assets, Goodwill and Other	12 Months Ended
Intangible Assets, Goodwill and Other	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure	Goodwill and Other Intangible Assets The changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2022 and 2021 were as follows: Personal Care Consumer Tissue K-C Professional Total Balance as of December 31, 2020 $ 984 $ 519 $ 392 $ 1,895 Acquisition 14 — — 14 Effect of foreign currency translation (37) (25) (7) (69) Balance as of December 31, 2021 961 494 385 1,840 Acquisition 304 — — 304 Effect of foreign currency translation (60) (6) (4) (70) Balance as of December 31, 2022 $ 1,205 $ 488 $ 381 $ 2,074 The changes in the carrying amount of Other Intangible Assets, Net for the years ended December 31, 2022 and 2021 were as follows: December 31 2022 2021 Gross Carrying Amount (b) Accumulated Amortization (b) Net Carrying Amount Gross Carrying Amount (b) Accumulated Amortization (b) Net Carrying Amount Intangible assets with indefinite lives: Brand names $ 610 $ — $ 610 $ 666 $ — $ 666 Intangibles assets with finite lives: Trademarks and brand names 253 (91) 162 140 (82) 58 Other intangible assets (a) 98 (19) 79 103 (17) 86 Total intangible assets with finite lives 351 (110) 241 243 (99) 144 Total $ 961 $ (110) $ 851 $ 909 $ (99) $ 810 (a) Other intangible assets primarily include customer and distributor relationships. (b) Amounts subject to foreign currency adjustments. Amortization expense relating to the intangible assets with finite lives was $15, $9 and $2 for the three years ended December 31, 2022, 2021 and 2020, respectively. Based on the carrying values of the intangible assets with finite lives as of December 31, 2022, amortization expense for each of the next five years is estimated to be approximately $17.

Fair Value Information

Fair Value Information	12 Months Ended
Fair Value Information	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Information	Fair Value Information The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are: Level 1—Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities. Level 2—Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly. Level 3—Prices or valuations that require inputs that are significant to the valuation and are unobservable. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During 2022 and 2021, there were no significant transfers to or from level 3 fair value determinations. Derivative assets and liabilities are measured on a recurring basis at fair value. At December 31, 2022 and 2021, derivative assets were $99 and $65, respectively, and derivative liabilities were $318 and $41 , respectively. The fair values of derivatives used to manage interest rate risk and commodity price risk are based on LIBOR rates and interest rate swap curves and commodity price quotations, respectively. The fair values of hedging instruments used to manage foreign currency risk are based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Measurement of our derivative assets and liabilities is considered a level 2 measurement. See Note 12 for additional information on our use of derivative instruments. Redeemable common and preferred securities of subsidiaries are measured on a recurring basis at their estimated redemption values, which approximates fair value. As of December 31, 2022 and 2021, the securities were valued at $258 and $26 respectively. No redeemable common securities were outstanding at December 31, 2021. The securities are not traded in active markets, and their measurement is considered a level 3 measurement. Company-owned life insurance ("COLI") assets are measured on a recurring basis at fair value. COLI assets were $63 and $72 at December 31, 2022 and 2021, respectively. The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in other assets. The COLI policies are measured at fair value using the net asset value per share practical expedient, and therefore, are not classified in the fair value hierarchy. The following table includes the fair value of our financial instruments for which disclosure of fair value is required: Fair Value Carrying Estimated Carrying Estimated December 31, 2022 December 31, 2021 Assets Cash and cash equivalents (a) 1 $ 427 $ 427 $ 270 $ 270 Time deposits (b) 1 268 268 416 416 Liabilities Short-term debt (c) 2 373 373 118 118 Long-term debt (d) 2 8,049 7,403 8,456 9,492 (a) Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. (b) Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value. (c) Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value. (d) Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Debt and Redeemable Preferred S

Debt and Redeemable Preferred Securities of Subsidiaries	12 Months Ended
Debt and Redeemable Preferred Securities of Subsidiaries	Dec. 31, 2022
Debt Disclosure [Abstract]
Debt and Redeemable Preferred Securities of Subsidiaries	Debt and Redeemable Common and Preferred Securities of Subsidiaries Long-term debt is composed of the following: Weighted- Maturities December 31 2022 2021 Notes and debentures 3.3% 2023 - 2050 $ 7,825 $ 8,198 Industrial development revenue bonds 4.6% 2023 - 2045 169 169 Bank loans and other financings in various currencies 2.5% 2023 - 2051 55 89 Total long-term debt 8,049 8,456 Less current portion 471 315 Long-term portion $ 7,578 $ 8,141 Scheduled maturities of long-term debt for the next five years are $472 in 2023, $524 in 2024, $550 in 2025, $396 in 2026 and $595 in 2027. In October 2021, we issued $600 aggregate principal amount of 2.00% notes due November 2, 2031. Proceeds from the offering were used for general corporate purposes. We maintain a $2.0 billion revolving credit facility which expires in June 2026 and a $775 revolving credit facility which expires in June 2023. These facilities, currently unused, support our commercial paper program, and would provide liquidity in the event our access to the commercial paper markets is unavailable for any reason.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
Stock-Based Compensation	Dec. 31, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Stock-Based Compensation	Stock-Based Compensation We have a stock-based Equity Participation Plan and an Outside Directors' Compensation Plan (the "Plans"), under which we can grant stock options, restricted shares and restricted share units to employees and outside directors. As of December 31, 2022, the number of shares of common stock available for grants under the Plans aggregated 9.5 million shares. Stock options are granted at an exercise price equal to the fair market value of our common stock on the date of grant, and they have a term of 10 years. Stock options are subject to graded vesting whereby options vest 30 percent at the end of each of the first two 12-month periods following the grant and 40 percent at the end of the third 12-month period. Time-vested restricted share unit grants starting in 2022 are valued at the closing market price of our common stock on the grant date and are generally subject to a graded vesting whereby shares vest 30 percent at the end of each of the first two 12-month periods following the grant and 40 percent at the end of the third 12-month period. Time-vested restricted share unit grants issued prior to 2022 or issued for special one-time awards, restricted shares units and performance-based restricted share units granted to employees are valued at the closing market price of our common stock on the grant date and vest generally at the end of three years. The number of performance-based share units that ultimately vest ranges from zero to 200 percent of the number granted based on performance. Beginning in 2021, performance metrics are tied to modified free cash flow and organic sales growth during the three-year performance period. Modified free cash flow and organic sales growth are set at the beginning of the performance period. Performance-based share units granted prior to 2021 are structured similarly but vest on performance tied to return on invested capital ("ROIC") and net sales. Restricted share units granted to outside directors are valued at the closing market price of our common stock on the grant date and vest when they are granted. The restricted period begins on the date of grant and expires on the date the outside director retires from or otherwise terminates service on our Board. At the time stock options are exercised or restricted shares and restricted share units become payable, common stock is issued from our accumulated treasury shares. Dividend equivalents are credited on restricted share units on the same date and at the same rate as dividends are paid on Kimberly-Clark's common stock. These dividend equivalents, net of estimated forfeitures, are charged to retained earnings. Stock-based compensation costs of $150, $26 and $147 and related deferred income tax benefits of $33, $7 and $32 were recognized for 2022, 2021 and 2020, respectively. The fair value of stock option awards was determined using a Black-Scholes-Merton option-pricing model utilizing a range of assumptions related to dividend yield, volatility, risk-free interest rate, and employee exercise behavior. Dividend yield is based on historical experience and expected future dividend actions. Expected volatility is based on a blend of historical volatility and implied volatility from traded options on Kimberly-Clark's common stock. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. We estimate forfeitures based on historical data. The weighted-average fair value of options granted was estimated at $21.28, $10.26 and $15.92 , in 2022, 2021 and 2020, respectively, per option on the date of grant based on the following assumptions: Year Ended December 31 2022 2021 2020 Dividend yield 3.3 % 3.9 % 3.3 % Volatility 22.1 % 17.4 % 21.9 % Risk-free interest rate 2.8 % 0.8 % 0.3 % Expected life - years 4.6 4.6 4.5 Total remaining unrecognized compensation costs and amortization period are as follows: December 31, 2022 Weighted-Average Stock options $ 10 0.6 Restricted shares and time-vested restricted share units 51 1.4 Performance-based restricted share units 31 1.6 A summary of stock-based compensation is presented below: Stock Options Shares Weighted-Average Weighted-Average Aggregate Intrinsic Outstanding at January 1, 2022 5,596 $ 126.01 Granted 655 116.28 Exercised (842) 113.00 Forfeited or expired (292) 127.70 Outstanding at December 31, 2022 5,117 126.81 5.73 $ 52 Exercisable at December 31, 2022 3,658 125.03 4.74 $ 42 The total intrinsic value of options exercised during 2022, 2021 and 2020 was $21, $16 and $62 , respectively. Time-Vested Performance-Based Other Stock-Based Awards Shares Weighted- Shares Weighted- Nonvested at January 1, 2022 393 $ 131.85 1,410 $ 131.03 Granted 718 131.37 517 133.24 Vested (172) 131.00 (672) 124.43 Forfeited (94) 137.25 (152) 134.60 Nonvested at December 31, 2022 845 134.81 1,103 138.96 The total fair value of restricted share units that were distributed to participants during 2022, 2021 and 2020 was $118, $100 and $62 , respectively.

Employee Postretirement Benefit

Employee Postretirement Benefits	12 Months Ended
Employee Postretirement Benefits	Dec. 31, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Employee Postretirement Benefits	Employee Postretirement Benefits Substantially all regular employees in the U.S. and the United Kingdom are covered by defined contribution retirement plans and certain U.S. and United Kingdom employees previously earned benefits covered by defined benefit pension plans that currently provide no future service benefit (the "Principal Plans"). Certain other subsidiaries have defined benefit pension plans or, in certain countries, termination pay plans covering substantially all regular employees. The funding policy for our qualified defined benefit pension plans is to contribute assets at least equal in amount to regulatory minimum requirements. Nonqualified U.S. plans providing pension benefits in excess of limitations imposed by the U.S. income tax code are not funded. Substantially all U.S. retirees and employees have access to our unfunded health care and life insurance benefit plans. The annual increase in the consolidated weighted-average health care cost trend rate is expected to be 5.7 percent in 2023 and to decline to 4.5 percent in 2030 and thereafter. Assumed health care cost trend rates affect the amounts reported for postretirement health care benefit plans. As a result of restructuring actions related to the 2018 Global Restructuring Program, aggregate pension settlement charges of $91, and $49 during 2021 and 2020, respectively, and curtailment gains of $2 during 2021 were recognized in Nonoperating expense, primarily related to the defined benefit pension plans in the U.S, Switzerland and the United Kingdom (see Note 2 for further information about the 2018 Global Restructuring Program). Summarized financial information about postretirement plans, excluding defined contribution retirement plans, is presented below: Pension Benefits Other Benefits Year Ended December 31 2022 2021 2022 2021 Change in Benefit Obligation Benefit obligation at beginning of year $ 3,811 $ 4,341 $ 669 $ 709 Service cost 16 21 7 8 Interest cost 89 80 21 19 Actuarial (gain) loss (a) (1,000) (105) (113) (8) Currency and other (197) (54) 2 (3) Benefit payments from plans (173) (138) — — Direct benefit payments (8) (8) (53) (54) Settlements and curtailments (97) (326) — (2) Benefit obligation at end of year 2,441 3,811 533 669 Change in Plan Assets Fair value of plan assets at beginning of year 3,744 4,193 — — Actual return on plan assets (987) 52 — — Employer contributions 30 10 — — Currency and other (199) (45) — — Benefit payments (173) (138) — — Settlements (94) (328) — — Fair value of plan assets at end of year 2,321 3,744 — — Funded Status $ (120) $ (67) $ (533) $ (669) (a) The actuarial net gains in 2022 and in 2021 were primarily due to discount rate increases. Substantially all of the funded status of pension and other benefits is recognized in the consolidated balance sheet in Noncurrent Employee Benefits, with the remainder recognized in Accrued expenses and other current liabilities and Other Assets. Information for the Principal Plans and All Other Pension Plans Principal Plans All Other Total Year Ended December 31 2022 2021 2022 2021 2022 2021 Projected benefit obligation (“PBO”) $ 2,089 $ 3,339 $ 352 $ 472 $ 2,441 $ 3,811 Accumulated benefit obligation (“ABO”) 2,089 3,339 305 408 2,394 3,747 Fair value of plan assets 2,018 3,389 303 355 2,321 3,744 Approximately one-half of the PBO and fair value of plan assets for the Principal Plans relate to the U.S. qualified and nonqualified pension plans. Information for Pension Plans with an ABO in Excess of Plan Assets December 31 2022 2021 ABO $ 1,251 $ 1,788 Fair value of plan assets 1,089 1,616 Information for Pension Plans with a PBO in Excess of Plan Assets December 31 2022 2021 PBO $ 1,261 $ 1,835 Fair value of plan assets 1,091 1,648 Components of Net Periodic Benefit Cost Pension Benefits Other Benefits Year Ended December 31 2022 2021 2020 2022 2021 2020 Service cost $ 16 $ 21 $ 22 $ 7 $ 8 $ 8 Interest cost 89 80 95 21 19 23 Expected return on plan assets (a) (123) (132) (134) — — — Recognized net actuarial loss 34 37 42 1 1 1 Settlements and curtailments 52 89 49 — — — Other 1 (5) (4) (1) (2) (2) Net periodic benefit cost $ 69 $ 90 $ 70 $ 28 $ 26 $ 30 (a) The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return. The components of net periodic benefit cost other than the service cost component are included in the line item Nonoperating expense in our consolidated income statement. Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended December 31 Pension Benefits Other Benefits Projected 2023 2022 2021 2020 2022 2021 2020 Discount rate 5.18 % 2.71 % 1.98 % 2.44 % 3.15 % 2.69 % 3.51 % Expected long-term return on plan assets 5.74 % 3.80 % 3.41 % 3.66 % — — — Rate of compensation increase 3.49 % 3.23 % 3.07 % 3.08 % — — — Weighted-Average Assumptions Used to Determine Benefit Obligations at December 31 Pension Benefits Other Benefits 2022 2021 2022 2021 Discount rate 5.18 % 2.36 % 5.92 % 3.15 % Rate of compensation increase 3.49 % 3.23 % — — Investment Strategies for the Principal Plans Strategic asset allocation decisions are made considering several risk factors, including plan participants' retirement benefit security, the estimated payments of the associated liabilities, the plan funded status, and Kimberly-Clark's financial condition. The resulting strategic asset allocation is a diversified blend of equity and fixed income investments. Equity investments are typically diversified across geographies and market capitalization. Fixed income investments are diversified across multiple sectors including government issues and corporate debt instruments with a portfolio duration that is consistent with the estimated payment of the associated liability. Actual asset allocation is regularly reviewed and periodically rebalanced to the strategic allocation when considered appropriate. Our 2023 target plan asset allocation for the Principal Plans is approximately 85 percent fixed income securities and 15 percent equity securities. The expected long-term rate of return is generally evaluated on an annual basis. In setting this assumption, we consider a number of factors including projected future returns by asset class relative to the current asset allocation. The weighted-average expected long-term rate of return on pension fund assets used to calculate pension expense for the Principal Plans was 3.55 percent in 2022, 3.51 percent in 2021 and 3.76 percent in 2020, and will be 6.05 percent in 2023. Set forth below are the pension plan assets of the Principal Plans measured at fair value, by level in the fair-value hierarchy. More than 65 percent of the assets are held in pooled funds and are measured using a net asset value (or its equivalent). Accordingly, such assets do not meet the Level 1, Level 2, or Level 3 criteria of the fair value hierarchy. Fair Value Measurements at December 31, 2022 Total Assets at Quoted Prices Assets at Significant Assets at Significant Cash and Cash Equivalents Held directly $ 69 $ 69 $ — $ — Held through mutual and pooled funds measured at net asset value 76 — — — Fixed Income Held directly U.S. government and municipals 115 115 — — U.S. corporate debt 193 — 193 — International bonds 33 — 33 — Held through mutual and pooled funds measured at net asset value U.S. government and municipals 71 — — — U.S. corporate debt 419 — — — International bonds 549 — — — Equity Held directly U.S. equity 21 21 — — International equity 15 15 — — Held through mutual and pooled funds measured at net asset value Non-U.S. equity 15 — — — Global equity 221 — — — Insurance Contracts 222 — — 222 Other (1) (1) — — Total Plan Assets $ 2,018 $ 219 $ 226 $ 222 Futures contracts are used when appropriate to manage duration targets. As of December 31, 2022 and 2021, the U.S. plan held directly Treasury futures contracts with a total notional value of approximately $362 and $377, respectively, and an insignificant fair value. As of December 31, 2022 and 2021, the United Kingdom plan held through a pooled fund future contracts with a total notional value of approximately $524 and $403, and an insignificant fair value. During 2022 and 2021, the plan assets did not include a significant amount of Kimberly-Clark common stock. Fair Value Measurements at December 31, 2021 Total Assets at Quoted Prices Assets at Significant Assets at Significant Cash and Cash Equivalents Held directly $ 50 $ 50 $ — $ — Held through mutual and pooled funds measured at net asset value 26 — — — Fixed Income Held directly U.S. government and municipals 166 158 8 — U.S. corporate debt 293 7 286 — International bonds 43 — 43 — Held through mutual and pooled funds measured at net asset value U.S. government and municipals 149 — — — U.S. corporate debt 646 — — — International bonds 1,144 — — — Equity Held directly U.S. equity 17 17 — — International equity 32 32 — — Held through mutual and pooled funds measured at net asset value Non-U.S. equity 46 — — — Global equity 423 — — — Insurance Contracts 355 — — 355 Other (1) 1 — — Total Plan Assets $ 3,389 $ 265 $ 337 $ 355 Inputs and valuation techniques used to measure the fair value of plan assets vary according to the type of security being valued. Substantially all of the equity securities held directly by the plans are actively traded and fair values are determined based on quoted market prices. Fair values of U.S. government securities are determined based on trading activity in the marketplace. Fair values of U.S. corporate debt, U.S. municipals and international bonds are typically determined by reference to the values of similar securities traded in the marketplace and current interest rate levels. Multiple pricing services are typically employed to assist in determining these valuations. Fair values of equity securities and fixed income securities held through units of pooled funds are based on net asset value of the units of the pooled fund determined by the fund manager. Pooled funds are similar in nature to retail mutual funds, but are typically more efficient for institutional investors. The fair value of pooled funds is determined by the value of the underlying assets held by the fund and the units outstanding. Equity securities held directly by the pension trusts and those held through units in pooled funds are monitored as to issuer and industry. Except for U.S. Treasuries, concentrations of fixed income securities are similarly monitored for concentrations by issuer and industry. As of December 31, 2022, there were no significant concentrations of equity or debt securities in any single issuer or industry. No level 3 transfers (in or out) were made in 2022 or 2021. Fair values of insurance contracts are based on an evaluation of various factors, including purchase price. We expect to contribute approximately $25 to our defined benefit pension plans in 2023. Over the next ten years, we expect that the following gross benefit payments will occur: Pension Benefits Other Benefits 2023 $ 179 $ 57 2024 190 58 2025 188 57 2026 189 56 2027 192 53 2028-2032 929 233 Defined Contribution Pension Plans Our 401(k) profit sharing plan and supplemental plan provide for a matching contribution of a U.S. employee's contributions and accruals, subject to predetermined limits, as well as a discretionary profit sharing contribution, in which contributions will be based on our profit performance. We also have defined contribution pension plans for certain employees outside the U.S. Costs charged to expense for our defined contribution pension plans were $132 in 2022, $116 in 2021, and $141 in 2020. Approximately 30 percent of these costs were for plans outside the U.S.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Dec. 31, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2020 $ (2,157) $ (912) $ (40) $ (63) Other comprehensive income (loss) before reclassifications (265) 37 9 53 (Income) loss reclassified from AOCI — 72 (a) (3) (a) 30 Net current period other comprehensive income (loss) (265) 109 6 83 Balance as of December 31, 2021 (2,422) (803) (34) 20 Other comprehensive income (loss) before reclassifications (347) (51) 86 (139) (Income) loss reclassified from AOCI — 65 (a) — (a) (44) Net current period other comprehensive income (loss) (347) 14 86 (183) Balance as of December 31, 2022 $ (2,769) $ (789) $ 52 $ (163) (a) Included in computation of net periodic pension and other postretirement benefits costs (see Note 8). Included in the above defined benefit pension plans and other postretirement benefit plans balances as of December 31, 2022 is $735 and $2 of unrecognized net actuarial loss and unrecognized net prior service credit, respectively. The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2022 2021 2020 Unrealized translation $ (324) $ (248) $ 98 Tax effect (23) (17) 16 (347) (265) 114 Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (109) 16 24 Amortization 34 37 41 Settlements and curtailments 52 91 49 Currency and other 36 10 (26) 13 154 88 Unrecognized prior service cost/credit Funded status recognition 2 (2) 2 Amortization — (4) (4) Curtailments — (3) — Currency and other — — 1 2 (9) (1) Tax effect (1) (36) (20) 14 109 67 Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other 113 12 (35) Tax effect (27) (6) 8 86 6 (27) Cash flow hedges and other Recognition of effective portion of hedges (165) 70 (32) Amortization (58) 39 (2) Currency and other (22) (4) (5) Tax effect 62 (22) 7 (183) 83 (32) Change in AOCI $ (430) $ (67) $ 122 Amounts are reclassified from AOCI into Cost of products sold, Nonoperating expense, Interest expense, or Other (income) and expense, net, as applicable, in the consolidated income statement. Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in AOCI. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. The change in unrealized translation in 2022 is primarily due to the weakening of various foreign currencies versus the U.S. dollar, particularly the Indonesian rupiah and the British pound. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

Leases and Commitments

Leases and Commitments	12 Months Ended
Leases and Commitments	Dec. 31, 2022
Leases [Abstract]
Lessee, Operating Leases [Text Block]	Leases and Commitments We have entered into leases for certain facilities, vehicles, material handling and other equipment. Our leases have remaining contractual terms up to 96 years, some of which include options to extend the leases for up to 99 years, and some of which include options to terminate the leases within 1 year. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Our lease costs are primarily related to facility leases for inventory warehousing and administration offices. Lease Expense Year Ended December 31 2022 2021 2020 Income Statement Classification Operating lease expense $ 145 $ 157 $ 168 Cost of products sold, Marketing, research and general expenses Finance lease expense: Amortization of lease assets 15 13 9 Cost of products sold Interest on lease liabilities 1 2 1 Interest expense Total finance lease expense 16 15 10 Variable lease expense (a) 242 219 202 Cost of products sold, Marketing, research and general expenses Total lease expense $ 403 $ 391 $ 380 (a) Includes short-term leases, which are immaterial. Lease Assets and Liabilities December 31 2022 2021 Balance Sheet Classification Assets Operating lease $ 475 $ 488 Other Assets Finance lease 71 86 Property, Plant and Equipment, Net Total lease assets $ 546 $ 574 Liabilities Current: Operating lease $ 127 $ 130 Accrued expenses and other current liabilities Finance lease 11 11 Debt payable within one year Noncurrent: Operating lease 377 393 Other Liabilities Finance lease 49 60 Long-Term Debt Total lease liabilities $ 564 $ 594 As of December 31, 2022 and 2021, accumulated amortization of finance lease asset s was $32 and $27, respectively. Maturity of Lease Liabilities December 31, 2022 Operating Leases Finance Leases Total 2023 $ 138 $ 13 $ 151 2024 119 10 129 2025 100 8 108 2026 83 6 89 2027 53 5 58 Thereafter 46 27 73 Total lease payments 539 69 608 Less imputed interest 35 9 44 Present value of lease liabilities $ 504 $ 60 $ 564 As of December 31, 2022, our operating leases have a weighted-average remaining lease term of 5 years and a weighted-average discount rate of 3 percent and our finance leases have a weighted-average remaining lease term of 8 years and a weighted-average discount rate of 3 percent . Supplemental Information Related to Leases December 31 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating leases $ 148 $ 155 $ 164 Finance leases 11 13 14 Lease assets obtained in exchange for new lease obligations: Operating leases 57 34 198 Finance leases 6 56 20 Other non-cash modifications to lease assets: Operating leases 72 61 98 We have entered into long-term contracts for the purchase of superabsorbent materials, pulp and certain utilities. Commitments under these contracts based on current prices are $1,794 in 2023, $958 in 2024, $798 in 2025, $279 in 2026, $252 in 2027, and $39 beyond the year 2027. Although we are primarily liable for payments on the above-mentioned leases and purchase commitments, our exposure to losses, if any, under these arrangements is not material.

Legal Matters

Legal Matters	12 Months Ended
Legal Matters	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Legal Matters	Legal MattersWe routinely are involved in legal proceedings, claims, disputes, tax matters, regulatory matters and governmental inspections or investigations arising in the ordinary course of or incidental to our business, including those noted below in this section. We record accruals in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. For the matters we disclose that do not include an estimate of the amount of loss or range of losses, such an estimate is not possible or is immaterial, and we may be unable to estimate the possible loss or range of losses that could potentially result from the application of non-monetary remedies, unless disclosed below. At present we believe that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations or cash flows. However, legal proceedings and government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could involve substantial monetary damages. In addition, in matters for which conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices or requiring other remedies. An unfavorable outcome might result in a material adverse impact on our business, results of operations or financial position. We are party to certain legal proceedings relating to our former health care business, Avanos Medical, Inc. ("Avanos", previously Halyard Health, Inc.), which we spun-off on October 31, 2014, including a qui tam matter and certain subpoena and document requests from the federal government. The subpoena and document requests include subpoenas from the United States Department of Justice (DOJ) concerning allegations of potential criminal and civil violations of federal laws, including the Food, Drug, and Cosmetic Act, in connection with the manufacturing, marketing and sale of surgical gowns by our former health care business. We continue to cooperate in this investigation and are making efforts to explore a potential resolution with the DOJ. We are subject to federal, state and local environmental protection laws and regulations with respect to our business operations and are operating in compliance with, or taking action aimed at ensuring compliance with, these laws and regulations. We have been named a potentially responsible party under the provisions of the U.S. federal Comprehensive Environmental Response, Compensation and Liability Act, or analogous state statutes, at a number of sites where hazardous substances are present. None of our compliance obligations with environmental protection laws and regulations, individually or in the aggregate, is expected to have a material adverse effect on our business, liquidity, financial condition or results of operations.

Objectives and Strategies for U

Objectives and Strategies for Using Derivatives	12 Months Ended
Objectives and Strategies for Using Derivatives	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Objectives and Strategies for Using Derivatives	Objectives and Strategies for Using Derivatives As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest rates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing activities and, where appropriate, the use of derivative instruments. At December 31, 2022 and 2021, derivative as sets were $99 and $65, respectively, and derivative liabilities were $318 and $41, respectively, primarily comprised of foreign currency exchange and commodity price contracts. Derivative assets are recorded in Other current assets or Other Assets, as appropriate, and derivative liabilities are recorded in Accrued expenses and other current liabilities or Other Liabilities, as appropriate. Foreign Currency Exchange Rate Risk Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowings. A portion of our balance sheet translation exposure for certain affiliates, which results from changes in translation rates between the affiliates’ functional currencies and the U.S. dollar, is hedged with cross-currency swap contracts and certain foreign denominated debt which are designated as net investment hedges. The foreign currency exposure on certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments. Derivative instruments are entered into to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated as cash flow hedges. Interest Rate Risk Interest rate risk is managed using a portfolio of variable and fixed-rate debt composed of short and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable and fixed-rate debt and are designated as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt, and these contracts are designated as cash flow hedges. Commodity Price Risk We use derivative instruments, such as forward contracts, to hedge a portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months. In addition, we utilize negotiated contracts of varying durations along with strategic pricing mechanisms to manage volatility for a portion of our commodity costs. Fair Value Hedges Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in current Interest expense. The offset to the change in fair values of the related debt is also recorded in Interest expense. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to Interest expense over the life of the related debt. As of December 31, 2022, the aggregate notional values and carrying values of debt subject to outstanding interest rate contracts designated as fair value hedges were $525 and $470, respectively. For each of the three years ended December 31, 2022, gains or losses recognized in Interest expense for interest rate swaps were not significant. Cash Flow Hedges For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same income statement line and period that the hedged exposure affects earnings. As of December 31, 2022, outstanding commodity forward contracts were in place to hedge a portion of our estimated requirements of the related underlying commodities in 2023 and future periods. As of December 31, 2022, the aggregate notional value of outstanding foreign exchange derivative contracts designated as cash flow hedges was $2.5 billion. For each of the three years ended December 31, 2022, no significant gains or losses were reclassified into Interest expense, Cost of products sold or Other (income) and expense, net as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring. At December 31, 2022, amounts to be reclassified from AOCI into Interest expense, Cost of products sold or Other (income), net during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at December 31, 2022 is December 2025. Net Investment Hedges For derivative instruments that are designated and qualify as net investment hedges, the aggregate notional value was $1.3 billion at December 31, 2022. We exclude the interest accruals on cross-currency swap contracts and the forward points on foreign exchange forward contracts from the assessment and measurement of hedge effectiveness. We recognize the interest accruals on cross-currency swap contracts in earnings within Interest expense. We amortize the forward points on foreign exchange contracts into earnings within Interest expense over the life of the hedging relationship. Changes in fair value of net investment hedges are recorded in AOCI and offset the change in the value of the net investment being hedged. For the year ended December 31, 2022, unrealized gain of $72 related to net investment hedge fair value changes were recorded in AOCI and no significant amounts were reclassified from AOCI to Interest expense. No significant amounts were excluded from the assessment of net investment, fair value or cash flow hedge effectiveness as of December 31, 2022. Undesignated Hedging Instruments Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in Other (income) and expense, net. A loss of $29, a loss of $5 and a gain of $39 were recorded in the years ending December 31, 2022, 2021 and 2020, respectively. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At December 31, 2022, the notional amount of these undesignated derivative instruments was approximately $2.2 billion.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes An analysis of the Provision for income taxes follows: Year Ended December 31 2022 2021 2020 Current income taxes United States $ 248 $ 179 $ 252 State 16 35 81 Other countries 288 335 298 Total 552 549 631 Deferred income taxes United States (27) (18) 62 State (1) (1) 5 Other countries (29) (51) (22) Total (57) (70) 45 Total provision for income taxes $ 495 $ 479 $ 676 The components of Income Before Income Taxes and Equity Interests follow: Year Ended December 31 2022 2021 2020 United States $ 1,802 $ 1,580 $ 2,336 Other countries 538 645 594 Total income before income taxes and equity interests $ 2,340 $ 2,225 $ 2,930 Deferred income tax assets and liabilities are comprised of the following: December 31 2022 2021 Deferred tax assets Pension and other postretirement benefits $ 179 $ 215 Tax credits and loss carryforwards 534 531 Capitalized research costs (a) 118 — Lease liability 116 116 Prepaid royalties 56 117 Derivatives 74 38 Other 353 317 1,430 1,334 Valuation allowances (299) (279) Total deferred tax assets 1,131 1,055 Deferred tax liabilities Property, plant and equipment, net 940 921 Investments in subsidiaries 101 105 Intangible assets 153 156 Lease asset 111 114 Other 229 228 Total deferred tax liabilities 1,534 1,524 Net deferred tax assets (liabilities) $ (403) $ (469) ( a) Capitalized research costs are attributable to research and development costs recorded as a period cost for financial reporting purposes but required to be capitalized for U.S. tax purposes and amortized primarily over a 5 period, beginning on January 1, 2022. Valuation allowances at the end of 2022 primarily relate to tax credits, capital loss carryforwards, and income tax loss carryforwards of $1.2 billion. If these items are not utilized against taxable income, $534 of the income tax loss carryforwards will expire from 2023 through 2039. The remaining $687 has no expiration date. Realization of income tax loss carryforwards is dependent on generating sufficient taxable income prior to expiration of these carryforwards. Although realization is not assured, we believe it is more likely than not that all of the deferred tax assets, net of applicable valuation allowances, will be realized. The amount of the deferred tax assets considered realizable could be reduced or increased due to changes in the tax environment or if estimates of future taxable income change during the carryforward period. Presented below is a reconciliation of the Provision for income taxes computed at the U.S. federal statutory tax rate to the actual effective tax rate: Year Ended December 31 2022 2021 2020 U.S. statutory rate applied to income before income taxes and equity interests 21.0 % 21.0 % 21.0 % State income taxes, net of federal tax benefit 0.5 1.2 2.3 Routine tax incentives (3.5) (5.8) (4.3) Net nondeductible expenses 1.4 1.5 0.8 Net tax cost on foreign income 2.4 2.4 2.7 Valuation allowance 1.3 2.4 0.7 Other - net (a) (1.9) (1.2) (0.1) Effective income tax rate 21.2 % 21.5 % 23.1 % (a) Other - net is composed of numerous items, none of which is greater than 1.05 percent of income before income taxes and equity interests. As of December 31, 2022, we have accumulated undistributed earnings generated by our foreign subsidiaries of approximately $7.4 billion . Earnings of $3.7 billion were previously subject to U.S. federal income tax. Any additional taxes due with respect to such previously-taxed foreign earnings, if repatriated, would generally be limited to foreign and U.S. state income taxes. Deferred taxes have been recorded on $0.7 billion of earnings of foreign consolidated subsidiaries expected to be repatriated. We do not intend to distribute the remaining $3.0 billion of previously-taxed foreign earnings and therefore have not recorded deferred taxes for foreign and U.S. state income taxes on such earnings. We consider any excess of the amount for financial reporting over tax basis in our foreign subsidiaries to be indefinitely reinvested. The determination of deferred tax liabilities on the amount of financial reporting over tax basis or the $3.0 billion of previously-taxed foreign earnings is not practicable. Presented below is a reconciliation of the beginning and ending amounts of unrecognized income tax benefits: 2022 2021 2020 Balance at January 1 $ 506 $ 497 $ 383 Gross increases for tax positions of prior years 22 62 144 Gross decreases for tax positions of prior years (38) (37) (34) Gross increases for tax positions of the current year 36 42 36 Settlements (21) (39) (22) Other (17) (19) (10) Balance at December 31 $ 488 $ 506 $ 497 Of the amounts recorded as unrecognized income tax benefits at December 31, 2022, $420 would reduce our effective tax rate if recognized. We recognize accrued interest and penalties related to unrecognized income tax benefits in Provision for income taxes. During each of the three years ended December 31, 2022, the net impact of interest and penalties was not significant. Total accrued penalties and net accrued interest was $35 and $24 at December 31, 2022 and 2021, respectively. It is reasonably possible that a number of uncertainties could be resolved within the next 12 months. The aggregate resolution of the uncertainties could be up to $130, whil e none of the uncertainties is individually significant. Resolution of these matters is not expected to have a material effect on our financial condition, results of operations or liquidity. As of December 31, 2022, the following tax years remain subject to examination for the major jurisdictions where we conduct business: Jurisdiction Years United States 2016 to 2022 United Kingdom 2020 to 2022 Brazil 2016 to 2022 China 2011 to 2022 South Korea 2020 to 2022 Our originally filed U.S. federal income tax returns have been audited through 2015; however, our amended U.S. federal income tax returns are subject to audit for 2013-2018. State income tax returns are generally subject to examination for a period of 3 to 5 years a fter filing of the respective return. The state effect of any changes to filed federal positions remains subject to examination by various states for a period of up to two years after formal notification to the states. We have various state income tax return positions in the process of examination, administrative appeals or litigation. The Brazilian tax authority, Secretaria da Receita Federal do Brasil ("RFB"), concluded an audit for the taxable periods from 2008-2013. This audit included a review of our determinations of amortization of certain goodwill arising from prior acquisitions in Brazil, and the RFB has proposed adjustments that effectively eliminate the goodwill amortization benefits related to these transactions. Administrative appeals have been exhausted with a partial favorable decision for our position, and the remaining dispute is in the judicial phase. Based upon the matters that remain in dispute, the amount of the proposed tax adjustments and penalties is approxima tely $60 as of Decembe r 31, 2022 (translated at the December 31, 2022 currency exchange rate). The amount ultimately in dispute will be significantly greater because of interest. We believe we have meritorious defenses and intend to vigorously defend against these proposed adjustments; however, it is expected to take a number of years to reach resolution of this matter. As part of the tax audit of our U.S. federal income tax returns for the taxable years ended December 31, 2017 and 2018, the U.S. Internal Revenue Service proposed an adjustment that would increase the amount of the one-time transition tax on certain undistributed earnings of foreign subsidiaries owed by us. We believe we have adequate reserves and meritorious defenses and intend to vigorously defend against the proposed adjustment; however, it is expected to take a number of years to reach resolution of this matter.

Earnings Per Share

Earnings Per Share	12 Months Ended
Earnings Per Share	Dec. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share ("EPS") There are no adjustments required to be made to net income for purposes of computing basic and diluted EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows: (Millions of shares) 2022 2021 2020 Basic 337.4 337.3 340.7 Dilutive effect of stock options and restricted share unit awards 0.9 1.5 1.8 Diluted 338.3 338.8 342.5 Options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares were insignificant. The number of common shares outstanding (in millions) as of December 31, 2022, 2021 and 2020 was 337.5, 336.8 and 338.7 , respectively.

Description of Business Segment

Description of Business Segments	12 Months Ended
Description of Business Segments	Dec. 31, 2022
Segment Reporting [Abstract]
Business Segment Information	Business Segment InformationWe are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments: Personal Care, Consumer Tissue and K-C Professional. The reportable segments were determined in accordance with how our chief operating decision maker and our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes Other (income) and expense, net and income and expense not associated with ongoing operations of the business segments, including the costs of corporate decisions related to the 2018 Global Restructuring Program which was completed in 2021 as described in Note 2, the amounts related to the acquisition of a controlling interest in Thinx in 2022 and the acquisition of Softex Indonesia in 2020 as described in Note 3, and business tax credits related to the resolution of certain Brazil tax matters in 2020 as described in Note 1. The principal sources of revenue in each global business segment are described below: • Personal Care brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex and other brand names. • Consumer Tissue offers a wide variety of innovative solutions and trusted brands that responsibly improve everyday living for families around the world. Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Andrex, Viva, Scottex, Neve and other brand names. • K-C Professional partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and KleenGuard are well known for quality and trusted to help people around the world work better. Net sales to Walmart Inc. as a percent of our consolidated net sales were approximately 13 percent in 2022, 14 percent in 2021 and 15 percent in 2020. Net sales to Walmart Inc. were primarily in the Personal Care and Consumer Tissue segments. Information concerning consolidated operations by business segment is presented in the following tables: Consolidated Operations by Business Segment Year Ended December 31 2022 2021 2020 NET SALES (a) Personal Care $ 10,622 $ 10,267 $ 9,339 Consumer Tissue 6,243 6,034 6,718 K-C Professional 3,256 3,072 3,019 Corporate & Other 54 67 64 TOTAL NET SALES $ 20,175 $ 19,440 $ 19,140 OPERATING PROFIT (b) Personal Care $ 1,787 $ 1,856 $ 1,933 Consumer Tissue 806 888 1,448 K-C Professional 457 404 528 Corporate & Other (c) (412) (559) (719) Other (income) and expense, net (d) (43) 28 (54) TOTAL OPERATING PROFIT $ 2,681 $ 2,561 $ 3,244 (a) Net sales in the U.S. to third parties totaled $9,848, $9,285 and $9,679 in 2022, 2021 and 2020, respectively. No other individual country's net sales exceeds 10 percent of total net sales. (b) Segment operating profit excludes Other (income) and expense, net and income and expenses not associated with the business segments. (c) Corporate & Other include s transaction and integration costs of $21 related to the acquisition of a controlling interest in Thinx in 2022 and charges of $265 and $392 related to the 2018 Global Restructuring Program in 2021 and 2020, respectively. Restructuring charges for the 2018 Global Restructuring Program related to the Personal Care, Consumer Tissue and K-C Professional business segments were $104, $118 and $40 for 2021 and $156, $176 and $53 for 2020, respectively. Corporate & Other also includes acquisition-related costs of $32 associated with the acquisition of Softex Indonesia in 2020. (d) Other (income) and expense, net for 2022 includes the non-cash, non-recurring gain of $85 related to the acquisition of a controlling interest in Thinx. For 2020, it includes business tax credits of $77 related to a favorable legal ruling that resolved certain matters related to prior years' business taxes in Brazil. Personal Consumer K-C Corporate Total Depreciation and Amortization 2022 $ 375 $ 251 $ 125 $ 3 $ 754 2021 355 291 116 4 766 2020 347 334 111 4 796 Capital Spending 2022 442 280 142 12 876 2021 536 303 157 11 1,007 2020 616 391 204 6 1,217 Assets 2022 9,086 5,048 2,675 1,161 17,970 2021 8,890 5,083 2,650 1,214 17,837 2020 8,486 5,227 2,551 1,259 17,523 Sales of Principal Products (Billions of dollars) 2022 2021 2020 Baby and child care products $ 7.2 $ 7.2 $ 6.4 Consumer tissue products 6.2 6.0 6.7 Away-from-home professional products 3.3 3.1 3.0 All other 3.5 3.1 3.0 Consolidated $ 20.2 $ 19.4 $ 19.1

Supplemental Data

Supplemental Data	12 Months Ended
Supplemental Data	Dec. 31, 2022
Supplemental Data
Supplemental Data	Supplemental Data Supplemental Income Statement Data Year Ended December 31 2022 2021 2020 Advertising expense $ 901 $ 893 $ 956 Research expense 292 269 276 Equity Companies' Data Net Gross Operating Net Corporation's 2022 $ 2,690 $ 707 $ 438 $ 240 $ 116 2021 2,501 696 398 205 98 2020 2,358 786 507 299 142 Current Noncurrent Current Noncurrent Stockholders' 2022 $ 1,585 $ 1,303 $ 814 $ 1,751 $ 323 2021 1,283 1,219 809 1,334 360 2020 1,585 1,203 842 1,563 382 Equity companies are principally engaged in operations in the personal care and consumer tissue businesses. At December 31, 2022, our ownership interest in Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries ("KCM") was 47.9 percent. KCM is partially owned by the public, and its stock is publicly traded in Mexico. At December 31, 2022, our investment in this equity company was $179, and the estimated fair value of the investment was $2.7 billion based on the market price of publicly traded shares. Our other equity ownership interests are not significant to our consolidated balance sheet or financial results. At December 31, 2022, undistributed net income of equity companies included in consolidated retained earnings was $1.1 billion. Supplemental Balance Sheet Data December 31 Summary of Accounts Receivable, Net 2022 2021 From customers $ 2,155 $ 2,092 Other 189 170 Less allowance for doubtful accounts and sales discounts (64) (55) Total $ 2,280 $ 2,207 December 31 2022 2021 Summary of Inventories by Major Class LIFO Non- Total LIFO Non- Total Raw materials $ 147 $ 425 $ 572 $ 141 $ 352 $ 493 Work in process 139 107 246 153 89 242 Finished goods 518 870 1,388 607 835 1,442 Supplies and other — 302 302 — 280 280 804 1,704 2,508 901 1,556 2,457 Excess of FIFO or weighted-average cost over LIFO cost (239) — (239) (218) — (218) Total $ 565 $ 1,704 $ 2,269 $ 683 $ 1,556 $ 2,239 Inventories are valued at the lower of cost or net realizable value, determined on the FIFO or weighted-average cost methods, and at the lower of cost or market, determined on the LIFO cost method. December 31 Summary of Property, Plant and Equipment, Net 2022 2021 Land $ 156 $ 169 Buildings 3,062 2,993 Machinery and equipment 14,655 14,606 Construction in progress 676 760 18,549 18,528 Less accumulated depreciation (10,664) (10,431) Total $ 7,885 $ 8,097 Property, plant and equipment, net in the U.S. as of December 31, 2022 and 2021 was $4,273 and $4,165 , respectively. December 31 Summary of Accrued Expenses and Other Current Liabilities 2022 2021 Accrued advertising and promotion $ 455 $ 434 Accrued salaries and wages 421 403 Accrued rebates 285 249 Accrued taxes - income and other 318 323 Operating leases 127 130 Accrued restructuring — 75 Accrued interest 82 85 Derivative liabilities 200 23 Other 401 374 Total $ 2,289 $ 2,096 Supplemental Cash Flow Statement Data Summary of Cash Flow Effects of Operating Working Capital Year Ended December 31 2022 2021 2020 Accounts receivable $ (151) $ (37) $ 95 Inventories (76) (417) (96) Trade accounts payable 109 627 239 Accrued expenses 92 (124) 132 Accrued income taxes 20 (4) 42 Derivatives 9 30 (9) Currency and other (20) (29) (40) Total $ (17) $ 46 $ 363 Year Ended December 31 Other Cash Flow Data 2022 2021 2020 Interest paid $ 270 $ 243 $ 245 Income taxes paid 468 492 533

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	12 Months Ended
Valuation and Qualifying Accounts	Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS FOR THE YEARS ENDED DECEMBER 31, 2022, 2021 AND 2020 (Millions of dollars) Description Balance at Additions Deductions Charged to Charged to Other Accounts (a) Write-Offs and Balance December 31, 2022 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 40 $ 14 $ (3) $ 4 (b) $ 47 Allowances for sales discounts 15 239 (3) 234 (c) 17 December 31, 2021 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 34 $ 12 $ (4) $ 2 (b) $ 40 Allowances for sales discounts 16 225 (2) 224 (c) 15 December 31, 2020 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 32 $ 3 $ 1 $ 2 (b) $ 34 Allowances for sales discounts 17 240 (3) 238 (c) 16 (a) Includes bad debt recoveries and the effects of changes in foreign currency exchange rates. (b) Primarily uncollectible receivables written off. (c) Sales discounts allowed. Additions Description Balance at Charged to Charged to Deductions (a) Balance December 31, 2022 Deferred taxes Valuation allowance $ 279 $ 37 $ — $ 17 $ 299 December 31, 2021 Deferred taxes Valuation allowance $ 272 $ 12 $ — $ 5 $ 279 December 31, 2020 Deferred taxes Valuation allowance $ 248 $ 21 $ — $ (3) $ 272 (a) Represents the net currency effects of translating valuation allowances at current rates of exchange.

Accounting Policies (Policy)

Accounting Policies (Policy)	12 Months Ended
Accounting Policies (Policy)	Dec. 31, 2022
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Actual results could differ from these estimates, and changes in these estimates are recorded when known. Estimates are used in accounting for, among other things, sales incentives and trade promotion allowances, employee postretirement benefits, and deferred income taxes and potential assessments.
Cash Equivalents	Cash Equivalents Cash equivalents are short-term investments with an original maturity date of three months or less.
Inventories and Distribution Costs	Inventories and Distribution Costs Most U.S. inventories are valued at the lower of cost, using the Last-In, First-Out ("LIFO") method, or market. The balance of the U.S. inventories and inventories of consolidated operations outside the U.S. are valued at the lower of cost or net realizable value using either the First-In, First-Out ("FIFO") or weighted-average cost methods. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Distribution costs are classified as cost of products sold.
Property and Depreciation	Property and Depreciation Property, plant and equipment are stated at cost and are depreciated on the straight-line method. Buildings are depreciated over their estimated useful lives, primarily 40 years. Machinery and equipment are depreciated over their estimated useful lives, primarily ranging from 16 to 20 years. Purchases of computer software, including external costs and certain internal costs (including payroll and payroll-related costs of employees) directly associated with developing significant computer software applications for internal use, are capitalized. Computer software costs are amortized on the straight-line method over the estimated useful life of the software, which generally does not exceed 5 years. Estimated useful lives are periodically reviewed and, when warranted, changes are made to them. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. An impairment loss would be indicated when estimated undiscounted future cash flows from the use and eventual disposition of an asset group, which are identifiable and largely independent of the cash flows of other asset groups, are less than the carrying amount of the asset group. Measurement of an impairment loss would be based on the excess of the carrying amount of the asset group over its fair value. Fair value is measured using discounted cash flows or independent appraisals, as appropriate. When property is sold or retired, the cost of the property and the related accumulated depreciation are removed from the consolidated balance sheet and any gain or loss on the transaction is included in income.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses. Goodwill is not amortized, but rather is assessed for impairment annually and whenever events and circumstances indicate that impairment may have occurred. Impairment testing compares the reporting unit carrying amount, including goodwill, with its fair value. If the reporting unit carrying amount, including goodwill, exceeds its fair value, a goodwill impairment charge for the excess amount above fair value would be recorded. In our evaluation of goodwill impairment, we have the option to first assess qualitative factors such as macroeconomic, industry and competitive conditions, legal and regulatory environments, historical and projected financial performance, significant changes in the reporting unit and the magnitude of excess fair value over carrying amount from the previous quantitative impairment testing. If the qualitative assessment determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then a quantitative impairment test using discounted cash flows to estimate fair value must be performed. Alternatively, if the qualitative assessment determines that it is more likely than not that the fair value of a reporting unit is more than its carrying value, then further quantitative testing is not required. For 2022, we completed the required annual assessment of goodwill for impairment for all of our reporting units using a qualitative assessment as of the first day of the third quarter, and we determined that it is more likely than not that the fair value of goodwill significantly exceeds the carrying amount for each of our reporting units. Indefinite-lived intangible assets, other than goodwill, consist of certain brand names related to our acquisition of Softex Indonesia and are tested for impairment annually at the same time as our goodwill impairment assessment and whenever events and circumstances indicate that impairment may have occurred. Our estimate of the fair value of our brand assets is based on a discounted cash flow model and a market-based approach using inputs which include projected revenues from our long-range plan, assumed royalty rates that could be payable if we did not own the brands, and a discount rate. For 2022, we completed the required annual assessment of indefinite-lived intangible assets, other than goodwill, for impairment using a qualitative assessment as of the first day of the third quarter, and we determined that it is more likely than not that the fair value is more than the carrying amount for each of these intangible assets. Intangible assets with finite lives are amortized over their estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. An impairment loss would be indicated when estimated undiscounted future cash flows from the use of the asset are less than its carrying amount. An impairment loss would be measured as the difference between the fair value (based on discounted future cash flows) and the carrying amount of the asset.
Investments in Equity Companies	Investments in Equity Companies Investments in companies which we do not control but over which we have the ability to exercise significant influence and that, in general, are at least 20 percent-owned by us, are stated at cost plus equity in undistributed net income. These investments are evaluated for impairment when warranted. An impairment loss would be recorded whenever a decline in value of an equity investment below its carrying amount is determined to be other than temporary. In judging "other than temporary," we would consider the length of time and extent to which the fair value of the equity company investment has been less than the carrying amount, the near-term and longer-term operating and financial prospects of the equity company, and our longer-term intent of retaining the investment in the equity company.
Revenue Recognition	Revenue Recognition Sales revenue is recognized at the time of product shipment or delivery, depending on when control passes, to unaffiliated customers, and when all of the following have occurred: a firm sales agreement is in place, pricing is fixed or determinable, and collection is reasonably assured. Sales are reported net of returns, consumer and trade promotions, rebates and freight allowed. Taxes imposed by governmental authorities on our revenue-producing activities with customers, such as sales taxes and value-added taxes, are excluded from net sales.
Sales Incentives and Trade Promotion Allowances	Sales Incentives and Trade Promotion Allowances The cost of promotion activities provided to customers is classified as a reduction in sales revenue. In addition, the estimated redemption value of consumer coupons and related expense are recorded when the related revenue from customers is realized. Rebate and promotion accruals are based on estimates of the quantity of customer sales. Promotion accruals also consider estimates of the number of consumer coupons that will be redeemed and timing and costs of activities within the promotional programs.
Advertising Expense	Advertising Expense Advertising costs are expensed in the year the related advertisement or campaign is first presented through traditional or digital media. For interim reporting purposes, advertising expenses are charged to operations as a percentage of sales based on estimated sales and related advertising expense for the full year.
Research Expense	Research Expense Research and development costs are charged to expense as incurred.
Foreign Currency Translation	Foreign Currency Translation The income statements of foreign operations, other than those in highly inflationary economies, are translated into U.S. dollars at rates of exchange in effect each month. The balance sheets of these operations are translated at period-end exchange rates, and the differences from historical exchange rates are reflected in stockholders' equity as unrealized translation adjustments. Under highly inflationary accounting, the countries' functional currency becomes the U.S. dollar, and its income statement and balance sheet are measured in U.S. dollar using both current and historical rates of exchange.
Highly Inflationary Accounting in Argentina	As of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiaries in Argentina (“K-C Argentina”). The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material . As of December 31, 2022, K-C Argentina had a small net peso monetary position. Net sales of K-C Argentina were approximate ly 1 percent of o
Derivative Instruments and Hedging	Derivative Instruments and Hedging Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments, interest rate swaps and locks, and the majority of commodity hedging contracts are entered into with major financial institutions. At inception, we formally designate certain derivatives as cash flow, fair value or net investment hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions or financial balances they are hedging. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings as they occur. All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The gain or loss on derivatives designated as fair value hedges and the offsetting loss or gain on the hedged item attributable to the hedged risk are included in income in the period that changes in fair value occur. The gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. The gain or loss on derivatives designated as hedges of investments in foreign subsidiaries is recognized in other comprehensive income to offset the change in value of the net investments being hedged. Certain foreign-currency derivative instruments not designated as hedging instruments have been entered into to manage certain non-functional currency denominated monetary assets and liabilities. The gain or loss on these derivatives is included in income in the period that changes in their fair values occur. Cash flows from derivatives are classified within the consolidated statement of cash flows in the same category as the items being hedged. Cash flows from derivatives are classified within Operating Activities, except for derivatives designated as net investment hedges which are classified in Investing Activities. See Note 12 for disclosures about derivative instruments and hedging activities.
Highly Inflationary Accounting in Turkey	As of April 1, 2022, we elected to adopt highly inflationary accounting for our subsidiary in Turkey (“K-C Turkey”). The effect of changes in exchange rates on lira-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material. As of December 31, 2022, K-C Turkey had a small net lira monetary position. Net sales of K-C Turkey were less than 1 percent of our consolidated net sales.

2018 Global Restructuring Pro_2

2018 Global Restructuring Program (Tables) - 2018 Global Restructuring Program	12 Months Ended
	Dec. 31, 2022
Restructuring Cost and Reserve
Restructuring and Related Costs	The following net charges were incurred in connection with the 2018 Global Restructuring Program: Year Ended December 31 2021 2020 2019 2018 Total Cost of products sold: Charges for workforce reductions $ 4 $ 10 $ 31 $ 149 $ 194 Asset impairments 3 17 — 74 94 Asset write-offs 17 63 54 112 246 Incremental depreciation 18 94 235 172 519 Other exit costs 112 99 96 34 341 Total 154 283 416 541 1,394 Marketing, research and general expenses: Charges for workforce reductions 39 13 (12) 243 283 Other exit costs 72 96 111 137 416 Total 111 109 99 380 699 Other (income) and expense, net (a) 10 (9) (194) (12) (205) Nonoperating expense (b) 79 36 45 127 287 Total charges 354 419 366 1,036 2,175 Provision for income taxes (75) (94) (118) (243) (530) Net charges 279 325 248 793 1,645 Net impact related to equity companies and 2 (2) — (10) (10) Net charges attributable to Kimberly-Clark $ 281 $ 323 $ 248 $ 783 $ 1,635 (a) Other (income) and expense, net in 2019 was the result of pre-tax gains on the sales of manufacturing facilities and associated real estate which were disposed of as part of the restructuring. (b) Represents non-cash pension settlement and curtailment charges resulting from restructuring actions, primarily in the U.S., United Kingdom and Canada.
Restructuring Liabilities Activity	The following summarizes the restructuring liabilities activity: 2021 Restructuring liabilities at January 1 $ 93 Charges for workforce reductions and other cash exit costs 222 Cash payments (235) Currency and other (2) Restructuring liabilities at December 31 $ 78

Acquisition (Tables)

Acquisition (Tables)	12 Months Ended
Acquisition (Tables)	Dec. 31, 2022
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The total purchase price consideration was allocated to the net assets acquired based upon their respective estimated fair values as follows: Current assets $ 28 Property, Plant and Equipment, Net 2 Goodwill 297 Other Intangible Assets, Net 123 Other assets 4 Current liabilities (17) Deferred income taxes (18) Other liabilities (4) Fair value of net assets acquired 415 Less fair value of noncontrolling interest (234) Total purchase price consideration $ 181

Intangible Assets, Goodwill a_2

Intangible Assets, Goodwill and Other (Tables)	12 Months Ended
Intangible Assets, Goodwill and Other (Tables)	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2022 and 2021 were as follows: Personal Care Consumer Tissue K-C Professional Total Balance as of December 31, 2020 $ 984 $ 519 $ 392 $ 1,895 Acquisition 14 — — 14 Effect of foreign currency translation (37) (25) (7) (69) Balance as of December 31, 2021 961 494 385 1,840 Acquisition 304 — — 304 Effect of foreign currency translation (60) (6) (4) (70) Balance as of December 31, 2022 $ 1,205 $ 488 $ 381 $ 2,074
Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class	The changes in the carrying amount of Other Intangible Assets, Net for the years ended December 31, 2022 and 2021 were as follows: December 31 2022 2021 Gross Carrying Amount (b) Accumulated Amortization (b) Net Carrying Amount Gross Carrying Amount (b) Accumulated Amortization (b) Net Carrying Amount Intangible assets with indefinite lives: Brand names $ 610 $ — $ 610 $ 666 $ — $ 666 Intangibles assets with finite lives: Trademarks and brand names 253 (91) 162 140 (82) 58 Other intangible assets (a) 98 (19) 79 103 (17) 86 Total intangible assets with finite lives 351 (110) 241 243 (99) 144 Total $ 961 $ (110) $ 851 $ 909 $ (99) $ 810 (a) Other intangible assets primarily include customer and distributor relationships. (b) Amounts subject to foreign currency adjustments.

Fair Value Information (Tables)

Fair Value Information (Tables)	12 Months Ended
Fair Value Information (Tables)	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair value of financial instruments	The following table includes the fair value of our financial instruments for which disclosure of fair value is required: Fair Value Carrying Estimated Carrying Estimated December 31, 2022 December 31, 2021 Assets Cash and cash equivalents (a) 1 $ 427 $ 427 $ 270 $ 270 Time deposits (b) 1 268 268 416 416 Liabilities Short-term debt (c) 2 373 373 118 118 Long-term debt (d) 2 8,049 7,403 8,456 9,492 (a) Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. (b) Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value. (c) Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value. (d) Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Debt and Reedemable Preferred S

Debt and Reedemable Preferred Securities of Subsidiaries (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Long-term debt	Long-term debt is composed of the following: Weighted- Maturities December 31 2022 2021 Notes and debentures 3.3% 2023 - 2050 $ 7,825 $ 8,198 Industrial development revenue bonds 4.6% 2023 - 2045 169 169 Bank loans and other financings in various currencies 2.5% 2023 - 2051 55 89 Total long-term debt 8,049 8,456 Less current portion 471 315 Long-term portion $ 7,578 $ 8,141

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
Stock-Based Compensation (Tables)	Dec. 31, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Schedule of weighted-average fair value of options, assumptions used	The weighted-average fair value of options granted was estimated at $21.28, $10.26 and $15.92 , in 2022, 2021 and 2020, respectively, per option on the date of grant based on the following assumptions: Year Ended December 31 2022 2021 2020 Dividend yield 3.3 % 3.9 % 3.3 % Volatility 22.1 % 17.4 % 21.9 % Risk-free interest rate 2.8 % 0.8 % 0.3 % Expected life - years 4.6 4.6 4.5
Schedule of total remaining unrecognized compensation costs and amortization period	Total remaining unrecognized compensation costs and amortization period are as follows: December 31, 2022 Weighted-Average Stock options $ 10 0.6 Restricted shares and time-vested restricted share units 51 1.4 Performance-based restricted share units 31 1.6
Summary of stock-based compensation	A summary of stock-based compensation is presented below: Stock Options Shares Weighted-Average Weighted-Average Aggregate Intrinsic Outstanding at January 1, 2022 5,596 $ 126.01 Granted 655 116.28 Exercised (842) 113.00 Forfeited or expired (292) 127.70 Outstanding at December 31, 2022 5,117 126.81 5.73 $ 52 Exercisable at December 31, 2022 3,658 125.03 4.74 $ 42
Summary of nonvested restricted share units	Time-Vested Performance-Based Other Stock-Based Awards Shares Weighted- Shares Weighted- Nonvested at January 1, 2022 393 $ 131.85 1,410 $ 131.03 Granted 718 131.37 517 133.24 Vested (172) 131.00 (672) 124.43 Forfeited (94) 137.25 (152) 134.60 Nonvested at December 31, 2022 845 134.81 1,103 138.96

Employee Postretirement Benef_2

Employee Postretirement Benefits (Tables)	12 Months Ended
Employee Postretirement Benefits (Tables)	Dec. 31, 2022	Dec. 31, 2021
Benefit Cost Information or Defined Benefit Plan and Other Postretirement Benefit Plan	Summarized financial information about postretirement plans, excluding defined contribution retirement plans, is presented below: Pension Benefits Other Benefits Year Ended December 31 2022 2021 2022 2021 Change in Benefit Obligation Benefit obligation at beginning of year $ 3,811 $ 4,341 $ 669 $ 709 Service cost 16 21 7 8 Interest cost 89 80 21 19 Actuarial (gain) loss (a) (1,000) (105) (113) (8) Currency and other (197) (54) 2 (3) Benefit payments from plans (173) (138) — — Direct benefit payments (8) (8) (53) (54) Settlements and curtailments (97) (326) — (2) Benefit obligation at end of year 2,441 3,811 533 669 Change in Plan Assets Fair value of plan assets at beginning of year 3,744 4,193 — — Actual return on plan assets (987) 52 — — Employer contributions 30 10 — — Currency and other (199) (45) — — Benefit payments (173) (138) — — Settlements (94) (328) — — Fair value of plan assets at end of year 2,321 3,744 — — Funded Status $ (120) $ (67) $ (533) $ (669) (a) The actuarial net gains in 2022 and in 2021 were primarily due to discount rate increases.
Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan	Information for the Principal Plans and All Other Pension Plans Principal Plans All Other Total Year Ended December 31 2022 2021 2022 2021 2022 2021 Projected benefit obligation (“PBO”) $ 2,089 $ 3,339 $ 352 $ 472 $ 2,441 $ 3,811 Accumulated benefit obligation (“ABO”) 2,089 3,339 305 408 2,394 3,747 Fair value of plan assets 2,018 3,389 303 355 2,321 3,744
Pension Plans with an ABO in Excess of Plan Assets	Information for Pension Plans with an ABO in Excess of Plan Assets December 31 2022 2021 ABO $ 1,251 $ 1,788 Fair value of plan assets 1,089 1,616
Pension Plans with a PBO in Excess of Plan Assets	Information for Pension Plans with a PBO in Excess of Plan Assets December 31 2022 2021 PBO $ 1,261 $ 1,835 Fair value of plan assets 1,091 1,648
Components of Net Periodic Benefit Cost	Components of Net Periodic Benefit Cost Pension Benefits Other Benefits Year Ended December 31 2022 2021 2020 2022 2021 2020 Service cost $ 16 $ 21 $ 22 $ 7 $ 8 $ 8 Interest cost 89 80 95 21 19 23 Expected return on plan assets (a) (123) (132) (134) — — — Recognized net actuarial loss 34 37 42 1 1 1 Settlements and curtailments 52 89 49 — — — Other 1 (5) (4) (1) (2) (2) Net periodic benefit cost $ 69 $ 90 $ 70 $ 28 $ 26 $ 30 (a) The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return.
Weighted-Average Assumptions Used to Determine Net Cost	Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended December 31 Pension Benefits Other Benefits Projected 2023 2022 2021 2020 2022 2021 2020 Discount rate 5.18 % 2.71 % 1.98 % 2.44 % 3.15 % 2.69 % 3.51 % Expected long-term return on plan assets 5.74 % 3.80 % 3.41 % 3.66 % — — — Rate of compensation increase 3.49 % 3.23 % 3.07 % 3.08 % — — — Weighted-Average Assumptions Used to Determine Benefit Obligations at December 31 Pension Benefits Other Benefits 2022 2021 2022 2021 Discount rate 5.18 % 2.36 % 5.92 % 3.15 % Rate of compensation increase 3.49 % 3.23 % — —
Estimated Future Benefit Payments	Over the next ten years, we expect that the following gross benefit payments will occur: Pension Benefits Other Benefits 2023 $ 179 $ 57 2024 190 58 2025 188 57 2026 189 56 2027 192 53 2028-2032 929 233
Pension Plan Assets of the Principal Plans Measured at Fair Value	Fair Value Measurements at December 31, 2022 Total Assets at Quoted Prices Assets at Significant Assets at Significant Cash and Cash Equivalents Held directly $ 69 $ 69 $ — $ — Held through mutual and pooled funds measured at net asset value 76 — — — Fixed Income Held directly U.S. government and municipals 115 115 — — U.S. corporate debt 193 — 193 — International bonds 33 — 33 — Held through mutual and pooled funds measured at net asset value U.S. government and municipals 71 — — — U.S. corporate debt 419 — — — International bonds 549 — — — Equity Held directly U.S. equity 21 21 — — International equity 15 15 — — Held through mutual and pooled funds measured at net asset value Non-U.S. equity 15 — — — Global equity 221 — — — Insurance Contracts 222 — — 222 Other (1) (1) — — Total Plan Assets $ 2,018 $ 219 $ 226 $ 222	Fair Value Measurements at December 31, 2021 Total Assets at Quoted Prices Assets at Significant Assets at Significant Cash and Cash Equivalents Held directly $ 50 $ 50 $ — $ — Held through mutual and pooled funds measured at net asset value 26 — — — Fixed Income Held directly U.S. government and municipals 166 158 8 — U.S. corporate debt 293 7 286 — International bonds 43 — 43 — Held through mutual and pooled funds measured at net asset value U.S. government and municipals 149 — — — U.S. corporate debt 646 — — — International bonds 1,144 — — — Equity Held directly U.S. equity 17 17 — — International equity 32 32 — — Held through mutual and pooled funds measured at net asset value Non-U.S. equity 46 — — — Global equity 423 — — — Insurance Contracts 355 — — 355 Other (1) 1 — — Total Plan Assets $ 3,389 $ 265 $ 337 $ 355

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
Stockholders' Equity (Tables)	Dec. 31, 2022
Equity [Abstract]
Components of AOCI attributable to Kimberly-Clark	The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2020 $ (2,157) $ (912) $ (40) $ (63) Other comprehensive income (loss) before reclassifications (265) 37 9 53 (Income) loss reclassified from AOCI — 72 (a) (3) (a) 30 Net current period other comprehensive income (loss) (265) 109 6 83 Balance as of December 31, 2021 (2,422) (803) (34) 20 Other comprehensive income (loss) before reclassifications (347) (51) 86 (139) (Income) loss reclassified from AOCI — 65 (a) — (a) (44) Net current period other comprehensive income (loss) (347) 14 86 (183) Balance as of December 31, 2022 $ (2,769) $ (789) $ 52 $ (163) (a) Included in computation of net periodic pension and other postretirement benefits costs (see Note 8).
Change in Components of Accumulated Other Comprehensive Income (Loss)	The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2022 2021 2020 Unrealized translation $ (324) $ (248) $ 98 Tax effect (23) (17) 16 (347) (265) 114 Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (109) 16 24 Amortization 34 37 41 Settlements and curtailments 52 91 49 Currency and other 36 10 (26) 13 154 88 Unrecognized prior service cost/credit Funded status recognition 2 (2) 2 Amortization — (4) (4) Curtailments — (3) — Currency and other — — 1 2 (9) (1) Tax effect (1) (36) (20) 14 109 67 Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other 113 12 (35) Tax effect (27) (6) 8 86 6 (27) Cash flow hedges and other Recognition of effective portion of hedges (165) 70 (32) Amortization (58) 39 (2) Currency and other (22) (4) (5) Tax effect 62 (22) 7 (183) 83 (32) Change in AOCI $ (430) $ (67) $ 122

Leases and Commitments (Tables)

Leases and Commitments (Tables)	12 Months Ended
Leases and Commitments (Tables)	Dec. 31, 2022
Leases [Abstract]
Operating Lease Cost	Lease Expense Year Ended December 31 2022 2021 2020 Income Statement Classification Operating lease expense $ 145 $ 157 $ 168 Cost of products sold, Marketing, research and general expenses Finance lease expense: Amortization of lease assets 15 13 9 Cost of products sold Interest on lease liabilities 1 2 1 Interest expense Total finance lease expense 16 15 10 Variable lease expense (a) 242 219 202 Cost of products sold, Marketing, research and general expenses Total lease expense $ 403 $ 391 $ 380 (a) Includes short-term leases, which are immaterial.
Operating Lease Assets and Liabilities	Lease Assets and Liabilities December 31 2022 2021 Balance Sheet Classification Assets Operating lease $ 475 $ 488 Other Assets Finance lease 71 86 Property, Plant and Equipment, Net Total lease assets $ 546 $ 574 Liabilities Current: Operating lease $ 127 $ 130 Accrued expenses and other current liabilities Finance lease 11 11 Debt payable within one year Noncurrent: Operating lease 377 393 Other Liabilities Finance lease 49 60 Long-Term Debt Total lease liabilities $ 564 $ 594
Maturity of Operating Lease Liabilities	Maturity of Lease Liabilities December 31, 2022 Operating Leases Finance Leases Total 2023 $ 138 $ 13 $ 151 2024 119 10 129 2025 100 8 108 2026 83 6 89 2027 53 5 58 Thereafter 46 27 73 Total lease payments 539 69 608 Less imputed interest 35 9 44 Present value of lease liabilities $ 504 $ 60 $ 564
Supplemental Information Related to Operating Leases	Supplemental Information Related to Leases December 31 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating leases $ 148 $ 155 $ 164 Finance leases 11 13 14 Lease assets obtained in exchange for new lease obligations: Operating leases 57 34 198 Finance leases 6 56 20 Other non-cash modifications to lease assets: Operating leases 72 61 98

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	An analysis of the Provision for income taxes follows: Year Ended December 31 2022 2021 2020 Current income taxes United States $ 248 $ 179 $ 252 State 16 35 81 Other countries 288 335 298 Total 552 549 631 Deferred income taxes United States (27) (18) 62 State (1) (1) 5 Other countries (29) (51) (22) Total (57) (70) 45 Total provision for income taxes $ 495 $ 479 $ 676
Schedule of Income before Income Tax, Domestic and Foreign	The components of Income Before Income Taxes and Equity Interests follow: Year Ended December 31 2022 2021 2020 United States $ 1,802 $ 1,580 $ 2,336 Other countries 538 645 594 Total income before income taxes and equity interests $ 2,340 $ 2,225 $ 2,930
Schedule of Deferred Tax Assets and Liabilities	Deferred income tax assets and liabilities are comprised of the following: December 31 2022 2021 Deferred tax assets Pension and other postretirement benefits $ 179 $ 215 Tax credits and loss carryforwards 534 531 Capitalized research costs (a) 118 — Lease liability 116 116 Prepaid royalties 56 117 Derivatives 74 38 Other 353 317 1,430 1,334 Valuation allowances (299) (279) Total deferred tax assets 1,131 1,055 Deferred tax liabilities Property, plant and equipment, net 940 921 Investments in subsidiaries 101 105 Intangible assets 153 156 Lease asset 111 114 Other 229 228 Total deferred tax liabilities 1,534 1,524 Net deferred tax assets (liabilities) $ (403) $ (469)
Schedule of Effective Income Tax Rate Reconciliation	Presented below is a reconciliation of the Provision for income taxes computed at the U.S. federal statutory tax rate to the actual effective tax rate: Year Ended December 31 2022 2021 2020 U.S. statutory rate applied to income before income taxes and equity interests 21.0 % 21.0 % 21.0 % State income taxes, net of federal tax benefit 0.5 1.2 2.3 Routine tax incentives (3.5) (5.8) (4.3) Net nondeductible expenses 1.4 1.5 0.8 Net tax cost on foreign income 2.4 2.4 2.7 Valuation allowance 1.3 2.4 0.7 Other - net (a) (1.9) (1.2) (0.1) Effective income tax rate 21.2 % 21.5 % 23.1 % (a) Other - net is composed of numerous items, none of which is greater than 1.05 percent of income before income taxes and equity interests.
Unrecognized Income Tax Benefits	Presented below is a reconciliation of the beginning and ending amounts of unrecognized income tax benefits: 2022 2021 2020 Balance at January 1 $ 506 $ 497 $ 383 Gross increases for tax positions of prior years 22 62 144 Gross decreases for tax positions of prior years (38) (37) (34) Gross increases for tax positions of the current year 36 42 36 Settlements (21) (39) (22) Other (17) (19) (10) Balance at December 31 $ 488 $ 506 $ 497
Summary of Income Tax Examinations	As of December 31, 2022, the following tax years remain subject to examination for the major jurisdictions where we conduct business: Jurisdiction Years United States 2016 to 2022 United Kingdom 2020 to 2022 Brazil 2016 to 2022 China 2011 to 2022 South Korea 2020 to 2022

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
Earnings Per Share (Tables)	Dec. 31, 2022
Earnings Per Share [Abstract]
Average Common Shares Outstanding Basic and Diluted	The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows: (Millions of shares) 2022 2021 2020 Basic 337.4 337.3 340.7 Dilutive effect of stock options and restricted share unit awards 0.9 1.5 1.8 Diluted 338.3 338.8 342.5

Business Segment and Geographic

Business Segment and Geographic Data Information (Tables)	12 Months Ended
Business Segment and Geographic Data Information (Tables)	Dec. 31, 2022
Segment Reporting Information
Information Concerning Consolidated Operations by Business Segment	Consolidated Operations by Business Segment Year Ended December 31 2022 2021 2020 NET SALES (a) Personal Care $ 10,622 $ 10,267 $ 9,339 Consumer Tissue 6,243 6,034 6,718 K-C Professional 3,256 3,072 3,019 Corporate & Other 54 67 64 TOTAL NET SALES $ 20,175 $ 19,440 $ 19,140 OPERATING PROFIT (b) Personal Care $ 1,787 $ 1,856 $ 1,933 Consumer Tissue 806 888 1,448 K-C Professional 457 404 528 Corporate & Other (c) (412) (559) (719) Other (income) and expense, net (d) (43) 28 (54) TOTAL OPERATING PROFIT $ 2,681 $ 2,561 $ 3,244 (a) Net sales in the U.S. to third parties totaled $9,848, $9,285 and $9,679 in 2022, 2021 and 2020, respectively. No other individual country's net sales exceeds 10 percent of total net sales. (b) Segment operating profit excludes Other (income) and expense, net and income and expenses not associated with the business segments. (c) Corporate & Other include s transaction and integration costs of $21 related to the acquisition of a controlling interest in Thinx in 2022 and charges of $265 and $392 related to the 2018 Global Restructuring Program in 2021 and 2020, respectively. Restructuring charges for the 2018 Global Restructuring Program related to the Personal Care, Consumer Tissue and K-C Professional business segments were $104, $118 and $40 for 2021 and $156, $176 and $53 for 2020, respectively. Corporate & Other also includes acquisition-related costs of $32 associated with the acquisition of Softex Indonesia in 2020. (d) Other (income) and expense, net for 2022 includes the non-cash, non-recurring gain of $85 related to the acquisition of a controlling interest in Thinx. For 2020, it includes business tax credits of $77 related to a favorable legal ruling that resolved certain matters related to prior years' business taxes in Brazil. Personal Consumer K-C Corporate Total Depreciation and Amortization 2022 $ 375 $ 251 $ 125 $ 3 $ 754 2021 355 291 116 4 766 2020 347 334 111 4 796 Capital Spending 2022 442 280 142 12 876 2021 536 303 157 11 1,007 2020 616 391 204 6 1,217 Assets 2022 9,086 5,048 2,675 1,161 17,970 2021 8,890 5,083 2,650 1,214 17,837 2020 8,486 5,227 2,551 1,259 17,523
Sales of Principal Products	Sales of Principal Products (Billions of dollars) 2022 2021 2020 Baby and child care products $ 7.2 $ 7.2 $ 6.4 Consumer tissue products 6.2 6.0 6.7 Away-from-home professional products 3.3 3.1 3.0 All other 3.5 3.1 3.0 Consolidated $ 20.2 $ 19.4 $ 19.1

Supplemental Data (Tables)

Supplemental Data (Tables)	12 Months Ended
Supplemental Data (Tables)	Dec. 31, 2022
Supplemental Income Statement Data	Supplemental Income Statement Data Year Ended December 31 2022 2021 2020 Advertising expense $ 901 $ 893 $ 956 Research expense 292 269 276
Equity Companies' Data	Equity Companies' Data Net Gross Operating Net Corporation's 2022 $ 2,690 $ 707 $ 438 $ 240 $ 116 2021 2,501 696 398 205 98 2020 2,358 786 507 299 142 Current Noncurrent Current Noncurrent Stockholders' 2022 $ 1,585 $ 1,303 $ 814 $ 1,751 $ 323 2021 1,283 1,219 809 1,334 360 2020 1,585 1,203 842 1,563 382
Summary of Inventories by Major Class	December 31 2022 2021 Summary of Inventories by Major Class LIFO Non- Total LIFO Non- Total Raw materials $ 147 $ 425 $ 572 $ 141 $ 352 $ 493 Work in process 139 107 246 153 89 242 Finished goods 518 870 1,388 607 835 1,442 Supplies and other — 302 302 — 280 280 804 1,704 2,508 901 1,556 2,457 Excess of FIFO or weighted-average cost over LIFO cost (239) — (239) (218) — (218) Total $ 565 $ 1,704 $ 2,269 $ 683 $ 1,556 $ 2,239
Property, Plant and Equipment	December 31 Summary of Property, Plant and Equipment, Net 2022 2021 Land $ 156 $ 169 Buildings 3,062 2,993 Machinery and equipment 14,655 14,606 Construction in progress 676 760 18,549 18,528 Less accumulated depreciation (10,664) (10,431) Total $ 7,885 $ 8,097
Schedule of Accrued Liabilities	December 31 Summary of Accrued Expenses and Other Current Liabilities 2022 2021 Accrued advertising and promotion $ 455 $ 434 Accrued salaries and wages 421 403 Accrued rebates 285 249 Accrued taxes - income and other 318 323 Operating leases 127 130 Accrued restructuring — 75 Accrued interest 82 85 Derivative liabilities 200 23 Other 401 374 Total $ 2,289 $ 2,096
Summary of Cash Flow Effects of Operating Working Capital	Supplemental Cash Flow Statement Data Summary of Cash Flow Effects of Operating Working Capital Year Ended December 31 2022 2021 2020 Accounts receivable $ (151) $ (37) $ 95 Inventories (76) (417) (96) Trade accounts payable 109 627 239 Accrued expenses 92 (124) 132 Accrued income taxes 20 (4) 42 Derivatives 9 30 (9) Currency and other (20) (29) (40) Total $ (17) $ 46 $ 363
Supplemental Cash Flow Data	Year Ended December 31 Other Cash Flow Data 2022 2021 2020 Interest paid $ 270 $ 243 $ 245 Income taxes paid 468 492 533
Accounts Receivable, Net
Supplemental Balance Sheet Data	December 31 Summary of Accounts Receivable, Net 2022 2021 From customers $ 2,155 $ 2,092 Other 189 170 Less allowance for doubtful accounts and sales discounts (64) (55) Total $ 2,280 $ 2,207

Accounting Policies (Narrative)

Accounting Policies (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain	$ 85	$ 0	$ 0
Thinx, Inc.
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain	$ 85
Other (income) and expense, net
Business tax credit, favorable legal ruling, foreign			$ 77
Trademarks \| Minimum
Intangible assets estimated useful life	10 years
Trademarks \| Maximum
Intangible assets estimated useful life	20 years
Patents, Developed Technologies & Other Intangible Assets \| Minimum
Intangible assets estimated useful life	4 years
Patents, Developed Technologies & Other Intangible Assets \| Maximum
Intangible assets estimated useful life	20 years
Building
Estimated useful life	40 years
Machinery and Equipment \| Minimum
Estimated useful life	16 years
Machinery and Equipment \| Maximum
Estimated useful life	20 years
Software
Estimated useful life	5 years
Net Sales Percentage to One Customer \| TURKEY \| Geographic Concentration Risk
Concentration Risk, Percentage	1%
Net Sales Percentage to One Customer \| ARGENTINA \| Geographic Concentration Risk
Concentration Risk, Percentage	1%

2018 Global Restructuring Pro_3

2018 Global Restructuring Program Narrative (Details) $ in Millions	12 Months Ended				48 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2021 USD ($) Employee	Dec. 31, 2022 USD ($)
Restructuring Cost and Reserve
Restructuring liabilities recorded in accrued expenses	$ 75				$ 75	$ 0
2018 Global Restructuring Program
Restructuring Cost and Reserve
Restructuring liabilities recorded in accrued expenses	75				75
Restructuring liabilities recorded in other liabilities	3				$ 3
Restructuring and Related Cost, Number of Positions Eliminated \| Employee					6,000
Payments for Restructuring	235	$ 249,000	$ 302,000	$ 325,000
Restructuring and Related Cost, Number of Positions Eliminated \| Employee					6,000
2018 Global Restructuring Program \| After Tax
Restructuring Cost and Reserve
Restructuring Charges	279	325	248	793	$ 1,645
Restructuring and Related Cost, Incurred Cost					1,600
2018 Global Restructuring Program \| Before Tax
Restructuring Cost and Reserve
Restructuring Charges	$ 354	$ 419	$ 366	$ 1,036	2,175
Restructuring and Related Cost, Incurred Cost					2,200
2018 Global Restructuring Program \| Cash charges
Restructuring Cost and Reserve
Restructuring and Related Cost, Incurred Cost					1,200
2018 Global Restructuring Program \| Non-cash charges \| Before Tax
Restructuring Cost and Reserve
Restructuring and Related Cost, Incurred Cost					$ 1,000

Restructuring and Related Activ

Restructuring and Related Activities (Details) - USD ($) $ in Millions	12 Months Ended					48 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2021
Restructuring Cost and Reserve
Asset impairments	$ 0	$ 3	$ 17
Provision for income taxes	$ (495)	(479)	(676)
2018 Global Restructuring Program
Restructuring Cost and Reserve
Provision for income taxes		(75)	(94)	$ (118)	$ (243)	$ (530)
2018 Global Restructuring Program \| Before Tax
Restructuring Cost and Reserve
Restructuring Charges		(354)	(419)	(366)	(1,036)	(2,175)
2018 Global Restructuring Program \| After Tax
Restructuring Cost and Reserve
Restructuring Charges		(279)	(325)	(248)	(793)	(1,645)
2018 Global Restructuring Program \| After Tax \| Equity Companies and Noncontrolling Interests
Restructuring Cost and Reserve
Restructuring Charges		(2)	2	0	10	10
2018 Global Restructuring Program \| After Tax \| Kimberly-Clark Corporation
Restructuring Cost and Reserve
Restructuring Charges		(281)	(323)	(248)	(783)	(1,635)
2018 Global Restructuring Program \| Cost of Sales \| Before Tax
Restructuring Cost and Reserve
Charges (adjustments) for workforce reductions		4	10	31	149	194
Asset impairments		3	17	0	74	94
Incremental depreciation		18	94	235	172	519
Other exit costs		112	99	96	34	341
Restructuring Charges		(154)	(283)	(416)	(541)	(1,394)
2018 Global Restructuring Program \| Cost of Sales \| Before Tax \| Asset write-offs
Restructuring Cost and Reserve
Restructuring Charges		(17)	(63)	(54)	(112)	(246)
2018 Global Restructuring Program \| Marketing, Research and General Expenses \| Before Tax
Restructuring Cost and Reserve
Charges (adjustments) for workforce reductions		39	13	(12)	243	283
Other exit costs		72	96	111	137	416
Restructuring Charges		(111)	(109)	(99)	(380)	(699)
2018 Global Restructuring Program \| Other (income) and expense, net \| Before Tax
Restructuring Cost and Reserve
Restructuring Charges		$ 10	$ (9)	$ (194)	$ (12)	$ (205)
2018 Global Restructuring Program \| Nonoperating (income) expense \| Before Tax
Restructuring Cost and Reserve
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]

[1]Represents non-cash pension settlement and curtailment charges resulting from restructuring actions, primarily in the U.S., United Kingdom and Canada.

2018 Global Restructuring Pro_4

2018 Global Restructuring Program Restructuring Reserve [Roll Forward] (Details) - 2018 Global Restructuring Program - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Restructuring Cost and Reserve
Restructuring liabilities - January 1	$ 93
Cash payments	(235)	$ (249,000)	$ (302,000)	$ (325,000)
Currency and other	(2)
Restructuring liabilities - December 31	78	$ 93
Workforce reductions and other cash exit costs
Restructuring Cost and Reserve
Charges for workforce reductions and other cash exit costs	$ 222

Acquisition (Details)

Acquisition (Details) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Business Combinations [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year Three		$ 17
Finite-Lived Intangible Asset, Expected Amortization, Year One		17
Finite-Lived Intangible Asset, Expected Amortization, Year Two		17
Finite-Lived Intangible Asset, Expected Amortization, Year Four		17
Finite-Lived Intangible Asset, Expected Amortization, Year Five		17
Goodwill	[1]	$ 2,074	$ 1,840	$ 1,895

[1]Stockholders' Equity The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2020 $ (2,157) $ (912) $ (40) $ (63) Other comprehensive income (loss) before reclassifications (265) 37 9 53 (Income) loss reclassified from AOCI — 72 (a) (3) (a) 30 Net current period other comprehensive income (loss) (265) 109 6 83 Balance as of December 31, 2021 (2,422) (803) (34) 20 Other comprehensive income (loss) before reclassifications (347) (51) 86 (139) (Income) loss reclassified from AOCI — 65 (a) — (a) (44) Net current period other comprehensive income (loss) (347) 14 86 (183) Balance as of December 31, 2022 $ (2,769) $ (789) $ 52 $ (163) (a) Included in computation of net periodic pension and other postretirement benefits costs (see Note 8). Included in the above defined benefit pension plans and other postretirement benefit plans balances as of December 31, 2022 is $735 and $2 of unrecognized net actuarial loss and unrecognized net prior service credit, respectively. The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2022 2021 2020 Unrealized translation $ (324) $ (248) $ 98 Tax effect (23) (17) 16 (347) (265) 114 Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (109) 16 24 Amortization 34 37 41 Settlements and curtailments 52 91 49 Currency and other 36 10 (26) 13 154 88 Unrecognized prior service cost/credit Funded status recognition 2 (2) 2 Amortization — (4) (4) Curtailments — (3) — Currency and other — — 1 2 (9) (1) Tax effect (1) (36) (20) 14 109 67 Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other 113 12 (35) Tax effect (27) (6) 8 86 6 (27) Cash flow hedges and other Recognition of effective portion of hedges (165) 70 (32) Amortization (58) 39 (2) Currency and other (22) (4) (5) Tax effect 62 (22) 7 (183) 83 (32) Change in AOCI $ (430) $ (67) $ 122 Amounts are reclassified from AOCI into Cost of products sold, Nonoperating expense, Interest expense, or Other (income) and expense, net, as applicable, in the consolidated income statement. Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in AOCI. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. The change in unrealized translation in 2022 is primarily due to the weakening of various foreign currencies versus the U.S. dollar, particularly the Indonesian rupiah and the British pound. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

Acquisition (Narrative) (Detail

Acquisition (Narrative) (Details) - USD ($) $ in Millions			12 Months Ended
Acquisition (Narrative) (Details) - USD ($) $ in Millions		Oct. 01, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Goodwill	[1]		$ 2,074	$ 1,840	$ 1,895
Finite-Lived Intangible Asset, Expected Amortization, Year One			17
Finite-Lived Intangible Asset, Expected Amortization, Year Two			17
Finite-Lived Intangible Asset, Expected Amortization, Year Four			17
Finite-Lived Intangible Asset, Expected Amortization, Year Five			17
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain			(85)	0	0
Finite-Lived Intangible Asset, Expected Amortization, Year Three			17
Softex Indonesia [Member]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Business Acquisition, Transaction Costs					32
Payments to Acquire Businesses, Gross		$ 1,200		1,100
Thinx, Inc.
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Goodwill			297
Payments to Acquire Businesses, Gross			53
Business Combination, Consideration Transferred			181
Equity Method Investments, Fair Value Disclosure			127
Share-Based Payment Arrangement, Accelerated Cost			$ 1
Sale of Stock, Percentage of Ownership after Transaction			58%
Finite-Lived Intangible Asset, Expected Amortization, Year One			$ 8
Finite-Lived Intangible Asset, Expected Amortization, Year Two			8
Finite-Lived Intangible Asset, Expected Amortization, Year Four			8
Finite-Lived Intangible Asset, Expected Amortization, Year Five			8
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain			(85)
Business Combination, Acquisition Related Costs			21
Finite-Lived Intangible Asset, Expected Amortization, Year Three			8
Before Tax \| Thinx, Inc.
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit			64
After Tax \| Thinx, Inc.
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain, Transaction and Related Costs, Net Benefit			68
Personal Care
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Goodwill	[1]		1,205	$ 961	$ 984
Personal Care \| Softex Indonesia [Member]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Goodwill			$ 404

[1]Stockholders' Equity The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2020 $ (2,157) $ (912) $ (40) $ (63) Other comprehensive income (loss) before reclassifications (265) 37 9 53 (Income) loss reclassified from AOCI — 72 (a) (3) (a) 30 Net current period other comprehensive income (loss) (265) 109 6 83 Balance as of December 31, 2021 (2,422) (803) (34) 20 Other comprehensive income (loss) before reclassifications (347) (51) 86 (139) (Income) loss reclassified from AOCI — 65 (a) — (a) (44) Net current period other comprehensive income (loss) (347) 14 86 (183) Balance as of December 31, 2022 $ (2,769) $ (789) $ 52 $ (163) (a) Included in computation of net periodic pension and other postretirement benefits costs (see Note 8). Included in the above defined benefit pension plans and other postretirement benefit plans balances as of December 31, 2022 is $735 and $2 of unrecognized net actuarial loss and unrecognized net prior service credit, respectively. The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2022 2021 2020 Unrealized translation $ (324) $ (248) $ 98 Tax effect (23) (17) 16 (347) (265) 114 Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (109) 16 24 Amortization 34 37 41 Settlements and curtailments 52 91 49 Currency and other 36 10 (26) 13 154 88 Unrecognized prior service cost/credit Funded status recognition 2 (2) 2 Amortization — (4) (4) Curtailments — (3) — Currency and other — — 1 2 (9) (1) Tax effect (1) (36) (20) 14 109 67 Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other 113 12 (35) Tax effect (27) (6) 8 86 6 (27) Cash flow hedges and other Recognition of effective portion of hedges (165) 70 (32) Amortization (58) 39 (2) Currency and other (22) (4) (5) Tax effect 62 (22) 7 (183) 83 (32) Change in AOCI $ (430) $ (67) $ 122 Amounts are reclassified from AOCI into Cost of products sold, Nonoperating expense, Interest expense, or Other (income) and expense, net, as applicable, in the consolidated income statement. Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in AOCI. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. The change in unrealized translation in 2022 is primarily due to the weakening of various foreign currencies versus the U.S. dollar, particularly the Indonesian rupiah and the British pound. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

Acquisition (Schedule of Recogn

Acquisition (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Goodwill	[1]	$ 2,074	$ 1,840	$ 1,895
Thinx, Inc.
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		28
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other		4
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities		(17)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		123
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		2
Goodwill		297
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities		(18)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other		(4)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		415
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value		(234)
Business Combination, Consideration Transferred		$ 181

[1]Stockholders' Equity The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2020 $ (2,157) $ (912) $ (40) $ (63) Other comprehensive income (loss) before reclassifications (265) 37 9 53 (Income) loss reclassified from AOCI — 72 (a) (3) (a) 30 Net current period other comprehensive income (loss) (265) 109 6 83 Balance as of December 31, 2021 (2,422) (803) (34) 20 Other comprehensive income (loss) before reclassifications (347) (51) 86 (139) (Income) loss reclassified from AOCI — 65 (a) — (a) (44) Net current period other comprehensive income (loss) (347) 14 86 (183) Balance as of December 31, 2022 $ (2,769) $ (789) $ 52 $ (163) (a) Included in computation of net periodic pension and other postretirement benefits costs (see Note 8). Included in the above defined benefit pension plans and other postretirement benefit plans balances as of December 31, 2022 is $735 and $2 of unrecognized net actuarial loss and unrecognized net prior service credit, respectively. The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2022 2021 2020 Unrealized translation $ (324) $ (248) $ 98 Tax effect (23) (17) 16 (347) (265) 114 Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (109) 16 24 Amortization 34 37 41 Settlements and curtailments 52 91 49 Currency and other 36 10 (26) 13 154 88 Unrecognized prior service cost/credit Funded status recognition 2 (2) 2 Amortization — (4) (4) Curtailments — (3) — Currency and other — — 1 2 (9) (1) Tax effect (1) (36) (20) 14 109 67 Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other 113 12 (35) Tax effect (27) (6) 8 86 6 (27) Cash flow hedges and other Recognition of effective portion of hedges (165) 70 (32) Amortization (58) 39 (2) Currency and other (22) (4) (5) Tax effect 62 (22) 7 (183) 83 (32) Change in AOCI $ (430) $ (67) $ 122 Amounts are reclassified from AOCI into Cost of products sold, Nonoperating expense, Interest expense, or Other (income) and expense, net, as applicable, in the consolidated income statement. Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in AOCI. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. The change in unrealized translation in 2022 is primarily due to the weakening of various foreign currencies versus the U.S. dollar, particularly the Indonesian rupiah and the British pound. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

Intangible Assets, Goodwill a_3

Intangible Assets, Goodwill and Other (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Line Items]
Goodwill, Acquired During Period		$ 304	$ 14
Goodwill, Foreign Currency Translation Gain (Loss)		(70)	(69)
Goodwill	[1]	2,074	1,840	$ 1,895
Amortization of Intangible Assets		15	9	2
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		241	144
Finite-Lived Intangible Assets, Accumulated Amortization		(110)	(99)
Finite-Lived Intangible Assets, Gross		351	243
Intangible Assets, Net (Excluding Goodwill)		851	810
Intangible Assets, Gross (Excluding Goodwill)		961	909
Brand Names
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill), Accumulated Amortization		0	0
Indefinite-Lived Intangible Assets (Excluding Goodwill), Net		610	666
Indefinite-Lived Intangible Assets (Excluding Goodwill), Gross		610	666
Personal Care
Goodwill [Line Items]
Goodwill, Acquired During Period		304	14
Goodwill, Foreign Currency Translation Gain (Loss)		(60)	(37)
Goodwill	[1]	1,205	961	984
Consumer Tissue
Goodwill [Line Items]
Goodwill, Acquired During Period		0	0
Goodwill, Foreign Currency Translation Gain (Loss)		(6)	(25)
Goodwill	[1]	488	494	519
K-C Professional and Other
Goodwill [Line Items]
Goodwill, Acquired During Period		0	0
Goodwill, Foreign Currency Translation Gain (Loss)		(4)	(7)
Goodwill	[1]	381	385	$ 392
Trademarks and brand names
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		162	58
Finite-Lived Intangible Assets, Accumulated Amortization		(91)	(82)
Finite-Lived Intangible Assets, Gross		253	140
Other Intangible Assets
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		79	86
Finite-Lived Intangible Assets, Accumulated Amortization		(19)	(17)
Other Finite-Lived Intangible Assets, Gross		$ 98	$ 103

[1]Stockholders' Equity The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2020 $ (2,157) $ (912) $ (40) $ (63) Other comprehensive income (loss) before reclassifications (265) 37 9 53 (Income) loss reclassified from AOCI — 72 (a) (3) (a) 30 Net current period other comprehensive income (loss) (265) 109 6 83 Balance as of December 31, 2021 (2,422) (803) (34) 20 Other comprehensive income (loss) before reclassifications (347) (51) 86 (139) (Income) loss reclassified from AOCI — 65 (a) — (a) (44) Net current period other comprehensive income (loss) (347) 14 86 (183) Balance as of December 31, 2022 $ (2,769) $ (789) $ 52 $ (163) (a) Included in computation of net periodic pension and other postretirement benefits costs (see Note 8). Included in the above defined benefit pension plans and other postretirement benefit plans balances as of December 31, 2022 is $735 and $2 of unrecognized net actuarial loss and unrecognized net prior service credit, respectively. The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2022 2021 2020 Unrealized translation $ (324) $ (248) $ 98 Tax effect (23) (17) 16 (347) (265) 114 Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (109) 16 24 Amortization 34 37 41 Settlements and curtailments 52 91 49 Currency and other 36 10 (26) 13 154 88 Unrecognized prior service cost/credit Funded status recognition 2 (2) 2 Amortization — (4) (4) Curtailments — (3) — Currency and other — — 1 2 (9) (1) Tax effect (1) (36) (20) 14 109 67 Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other 113 12 (35) Tax effect (27) (6) 8 86 6 (27) Cash flow hedges and other Recognition of effective portion of hedges (165) 70 (32) Amortization (58) 39 (2) Currency and other (22) (4) (5) Tax effect 62 (22) 7 (183) 83 (32) Change in AOCI $ (430) $ (67) $ 122 Amounts are reclassified from AOCI into Cost of products sold, Nonoperating expense, Interest expense, or Other (income) and expense, net, as applicable, in the consolidated income statement. Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in AOCI. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. The change in unrealized translation in 2022 is primarily due to the weakening of various foreign currencies versus the U.S. dollar, particularly the Indonesian rupiah and the British pound. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 15	$ 9	$ 2
Finite-Lived Intangible Asset, Expected Amortization, Year Five	17
Finite-Lived Intangible Asset, Expected Amortization, Year Three	17
Finite-Lived Intangible Asset, Expected Amortization, Year Four	17
Finite-Lived Intangible Asset, Expected Amortization, Year Two	17
Finite-Lived Intangible Asset, Expected Amortization, Year One	$ 17

Fair Value Information Narrativ

Fair Value Information Narrative (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative Assets	$ 99	$ 65
Derivative Liability	318	41
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Redeemable Preferred Securities Of Subsidiaries Fair Value Disclosure	258	26
Net Asset Value or Its Equivalent
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Company-owned life insurance (COLI)	$ 63	$ 72

Fair Value Information (Fair Va

Fair Value Information (Fair Value of Financial Instruments) (Details) - USD ($) $ in Millions		Dec. 31, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Cash and cash equivalents		$ 427	$ 270
Fair Value, Inputs, Level 1 \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Time Deposits, at Carrying Value	[1]	268	416
Cash and cash equivalents	[2]	427	270
Fair Value, Inputs, Level 1 \| Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Cash and cash equivalents	[2]	427	270
Time Deposits	[1]	268	416
Fair Value, Inputs, Level 2 \| Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Short-term Debt	[3]	373	118
Long-term Debt	[4]	8,049	8,456
Fair Value, Inputs, Level 2 \| Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Short-term debt	[3]	373	118
Long-term Debt, Fair Value	[4]	$ 7,403	$ 9,492

[1]Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.[2]Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.[3]Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.[4]Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Debt and Redeemable Preferred_2

Debt and Redeemable Preferred Securities of Subsidiaries (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument
Scheduled maturity of long-term debt in 2020	$ 472
Scheduled maturity of long-term debt in 2021	524
Scheduled maturity of long-term debt in 2022	550
Scheduled maturity of long-term debt in 2023	396
Scheduled maturity of long-term debt in 2024	595
2.00% Notes due November 2, 2031
Debt Instrument
Face amount of note		$ 600
Interest rate of note		2%
Credit facility expiring June 2026
Debt Instrument
Revolving credit facility	2,000
Credit facility expiring June 2022
Debt Instrument
Revolving credit facility	$ 775

Debt and Redeemable Preferred_3

Debt and Redeemable Preferred Securities of Subsidiaries (Long-Term Debt) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument
Total Long-term debt	$ 8,049	$ 8,456
Less current portion	471	315
Long-term portion	$ 7,578	8,141
Notes and debentures
Debt Instrument
Weighted- Average Interest Rate	3.30%
Total Long-term debt	$ 7,825	8,198
Industrial development revenue bonds
Debt Instrument
Weighted- Average Interest Rate	4.60%
Total Long-term debt	$ 169	169
Bank loans and other financings In various currencies
Debt Instrument
Weighted- Average Interest Rate	2.50%
Total Long-term debt	$ 55	$ 89

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award
Shares of common stock available for grants	9,500,000
Stock-based compensation	$ 150	$ 26	$ 147
Deferred income tax benefits on stock-based compensation	$ 33	$ 7	$ 32
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Stock options term, years	10 years
Vesting percentage at the end of each of the first two 12 months period	30%
Vesting percentage at the end of third 12 months period	40%
Weighted-average fair value of options granted	$ 21.28	$ 10.26	$ 15.92
Total intrinsic value of options exercised	$ 21	$ 16	$ 62
Restricted share units
Share-based Compensation Arrangement by Share-based Payment Award
Restricted shares vesting period	3 years
Total fair value of restricted share units distributed	$ 118	$ 100	$ 62
Performance-based restricted share units \| Minimum \| Share-based Compensation Award
Share-based Compensation Arrangement by Share-based Payment Award
Number of performance-based share units that vest, percentage	0%
Performance-based restricted share units \| Maximum \| Share-based Compensation Award
Share-based Compensation Arrangement by Share-based Payment Award
Number of performance-based share units that vest, percentage	200%

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule of Assumptions Used to Estimate Weighted-Average Fair Value of Options Granted) (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Dividend yield	3.30%	3.90%	3.30%
Volatility	22.10%	17.40%	21.90%
Risk-free interest rate	2.80%	0.80%	0.30%
Expected life - years	4 years 7 months 6 days	4 years 7 months 6 days	4 years 6 months

Stock-Based Compensation (Sch_2

Stock-Based Compensation (Schedule of Unrecognized Compensation Costs and Amortization Periods) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Stock options	$ 10
Weighted-Average Service Years	7 months 6 days
Restricted share units
Share-based Compensation Arrangement by Share-based Payment Award
Total remaining unrecognized compensation costs, nonvested awards other than options	$ 51
Weighted-Average Service Years	1 year 4 months 24 days
Performance-based restricted share units
Share-based Compensation Arrangement by Share-based Payment Award
Total remaining unrecognized compensation costs, nonvested awards other than options	$ 31
Weighted-Average Service Years	1 year 7 months 6 days

Stock-Based Compensation (Sch_3

Stock-Based Compensation (Schedule of Stock-Based Compensation Activity) (Details) - Stock Option $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding
Outstanding at January 1, 2019 \| shares	5,596
Granted \| shares	655
Exercised \| shares	(842)
Forfeited or expired \| shares	(292)
Outstanding at December 31, 2019 \| shares	5,117
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding at January 1, Weighted-Average Exercise Price \| $ / shares	$ 126.01
Granted, Weighted-Average Exercise Price \| $ / shares	116.28
Exercised, Weighted-Average Exercise Price \| $ / shares	113
Forfeited or expired, Weighted-Average Exercise Price \| $ / shares	127.70
Outstanding at December 31, Weighted-Average Exercise Price \| $ / shares	$ 126.81
Exercisable at December 31, 2019 \| shares	3,658
Exercisable at December 31, Weighted-Average Exercise Price \| $ / shares	$ 125.03
Outstanding at December 31, Weighted-Average Remaining Contractual Term	5 years 8 months 23 days
Exercisable at December 31, Weighted-Average Remaining Contractual Term	4 years 8 months 26 days
Outstanding at December 31, Aggregate Intrinsic Value \| $	$ 52
Exercisable at December 31, Aggregate Intrinsic Value \| $	$ 42

Stock-Based Compensation (Sch_4

Stock-Based Compensation (Schedule of Other Stock-Based Awards Activity) (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Time-Vested Restricted Share Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Nonvested at January 1, 2019 \| shares	393
Granted \| shares	718
Vested \| shares	(172)
Forfeited \| shares	(94)
Nonvested at December 31, 2019 \| shares	845
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Nonvested at January 1, 2019, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 131.85
Granted, Weighted-Average Grant-Date Fair Value \| $ / shares	131.37
Vested, Weighted-Average Grant-Date Fair Value \| $ / shares	131
Forfeited, Weighted-Average Grant-Date Fair Value \| $ / shares	137.25
Nonvested at December 31, 2019, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 134.81
Performance-based restricted share units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Nonvested at January 1, 2019 \| shares	1,410
Granted \| shares	517
Vested \| shares	(672)
Forfeited \| shares	(152)
Nonvested at December 31, 2019 \| shares	1,103
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Nonvested at January 1, 2019, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 131.03
Granted, Weighted-Average Grant-Date Fair Value \| $ / shares	133.24
Vested, Weighted-Average Grant-Date Fair Value \| $ / shares	124.43
Forfeited, Weighted-Average Grant-Date Fair Value \| $ / shares	134.60
Nonvested at December 31, 2019, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 138.96

Employee Postretirement Benef_3

Employee Postretirement Benefits (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2030
Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate		2030
Defined Contribution Plan, Cost		$ 132	$ 116	$ 141
Scenario, Forecast
Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year	5.70%
Defined Benefit Plan, Health Care Cost Trend Rate Assumed For Ultimate Fiscal Year					4.50%
U.S. Pension Plan
Derivative, Notional Amount		362	377
U.K. Pension Plan
Derivative, Notional Amount		$ 524	$ 403
Principal Plans
Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description		there were no significant concentrations of equity or debt securities in any single issuer or industry.
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets		3.55%	3.51%	3.76%
Principal Plans \| Scenario, Forecast
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets	6.05%
Defined Benefit Pension Plans
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets		3.80%	3.41%	3.66%
Defined Benefit Pension Plans \| Scenario, Forecast
Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year	$ 25
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets	5.74%
Equity Securities \| Principal Plans \| Scenario, Forecast
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage	15%
2018 Global Restructuring Program
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement			$ (91)	$ (49)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment			$ (2)
Fixed Income Funds \| Principal Plans \| Scenario, Forecast
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage	85%

Employee Postretirement Benef_4

Employee Postretirement Benefits (Summarized Financial Information about Postretirement plans, Excluding Defined Contribution Retirement Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Pension Plans
Benefit obligation at beginning of year	$ 3,811	$ 4,341
Service cost	16	21	$ 22
Interest cost	89	80	95
Actuarial (gain) loss(a)	(1,000)	(105)
Currency and other	(197)	(54)
Benefit payments from plans	(173)	(138)
Direct benefit payments	(8)	(8)
Settlements and curtailments	(97)	(326)
Benefit obligation at end of year	2,441	3,811	4,341
Fair value of plan assets at beginning of year	3,744	4,193
Actual return on plan assets	(987)	52
Employer contributions	30	10
Currency and other	(199)	(45)
Benefit payments	(173)	(138)
Settlements	(94)	(328)
Fair value of plan assets at end of year	2,321	3,744	4,193
Funded Status	(120)	(67)
Other Postretirement Benefit Plans
Benefit obligation at beginning of year	669	709
Service cost	7	8	8
Interest cost	21	19	23
Actuarial (gain) loss(a)	(113)	(8)
Currency and other	2	(3)
Benefit payments from plans	0	0
Direct benefit payments	(53)	(54)
Settlements and curtailments	0	(2)
Benefit obligation at end of year	533	669	709
Fair value of plan assets at beginning of year	0	0
Actual return on plan assets	0	0
Employer contributions	0	0
Currency and other	0	0
Benefit payments	0	0
Settlements	0	0
Fair value of plan assets at end of year	0	0	$ 0
Funded Status	$ (533)	$ (669)

Employee Postretirement Benef_5

Employee Postretirement Benefits (Principal Plans and All Other Pension Plans) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Principal Plans
Projected benefit obligation (PBO)	$ 2,089	$ 3,339
Accumulated benefit obligation (ABO)	2,089	3,339
Fair value of plan assets	2,018	3,389
All Other Pension Plans
Projected benefit obligation (PBO)	352	472
Accumulated benefit obligation (ABO)	305	408
Fair value of plan assets	303	355
Defined Benefit Pension Plans
Projected benefit obligation (PBO)	2,441	3,811	$ 4,341
Accumulated benefit obligation (ABO)	2,394	3,747
Fair value of plan assets	$ 2,321	$ 3,744	$ 4,193

Employee Postretirement Benef_6

Employee Postretirement Benefits (Pension Plans with an ABO in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
ABO	$ 1,251	$ 1,788
Fair value of plan assets	$ 1,089	$ 1,616

Employee Postretirement Benef_7

Employee Postretirement Benefits Employee Postretirement Benefits (Pension Plans with a PBO in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
PBO	$ 1,261	$ 1,835
Fair value of plan assets	$ 1,091	$ 1,648

Employee Postretirement Benef_8

Employee Postretirement Benefits (Components of Net Periodic Benefit Cost) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Pension Plans
Service cost		$ 16	$ 21	$ 22
Interest cost		89	80	95
Expected return on plan assets	[1]	(123)	(132)	(134)
Recognized net actuarial loss		34	37	42
Other		1	(5)	(4)
Net periodic benefit cost		69	90	70
Defined Benefit Pension Plans \| Nonoperating (income) expense
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment		(52)	(89)	(49)
Other Postretirement Benefit Plans
Service cost		7	8	8
Interest cost		21	19	23
Expected return on plan assets	[1]	0	0	0
Recognized net actuarial loss		1	1	1
Other		(1)	(2)	(2)
Net periodic benefit cost		28	26	30
Other Pension Plan \| Nonoperating (income) expense
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment		$ 0	$ 0	$ 0

[1]The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return.

Employee Postretirement Benef_9

Employee Postretirement Benefits (Weighted-Average Assumptions) (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Pension Plans
Net cost, Discount rate		2.71%	1.98%	2.44%
Expected long-term return on plan assets		3.80%	3.41%	3.66%
Net cost, Rate of compensation increase		3.23%	3.07%	3.08%
Benefit obligations, Discount rate		5.18%	2.36%
Benefit obligations, Rate of compensation increase		3.49%	3.23%
Defined Benefit Pension Plans \| Scenario, Forecast
Net cost, Discount rate	5.18%
Expected long-term return on plan assets	5.74%
Net cost, Rate of compensation increase	3.49%
Other Postretirement Benefit Plans
Net cost, Discount rate		3.15%	2.69%	3.51%
Expected long-term return on plan assets		0%	0%	0%
Net cost, Rate of compensation increase		0%	0%	0%
Benefit obligations, Discount rate		5.92%	3.15%
Benefit obligations, Rate of compensation increase		0%	0%

Employee Postretirement Bene_10

Employee Postretirement Benefits (Pension Plan Assets of the Principal Plans Measured at fair value) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Principal Plans
Fair value of plan assets	$ 2,018	$ 3,389
Principal Plans \| Fair Value, Inputs, Level 1
Fair value of plan assets	219	265
Principal Plans \| Fair Value, Inputs, Level 2
Fair value of plan assets	226	337
Principal Plans \| Fair Value, Inputs, Level 3
Fair value of plan assets	222	355
Principal Plans \| Cash and Cash Equivalents
Fair value of plan assets	69	50
Principal Plans \| Cash and Cash Equivalents \| Net Asset Value or Its Equivalent
Fair value of plan assets	76	26
Principal Plans \| Cash and Cash Equivalents \| Fair Value, Inputs, Level 1
Fair value of plan assets	69	50
Principal Plans \| U.S. government and municipals
Fair value of plan assets	115	166
Principal Plans \| U.S. government and municipals \| Net Asset Value or Its Equivalent
Fair value of plan assets	71	149
Principal Plans \| U.S. government and municipals \| Fair Value, Inputs, Level 1
Fair value of plan assets	115	158
Principal Plans \| U.S. government and municipals \| Fair Value, Inputs, Level 2
Fair value of plan assets		8
Principal Plans \| U.S. corporate debt
Fair value of plan assets	193	293
Principal Plans \| U.S. corporate debt \| Net Asset Value or Its Equivalent
Fair value of plan assets	419	646
Principal Plans \| U.S. corporate debt \| Fair Value, Inputs, Level 1
Fair value of plan assets		7
Principal Plans \| U.S. corporate debt \| Fair Value, Inputs, Level 2
Fair value of plan assets	193	286
Principal Plans \| International bonds
Fair value of plan assets	33	43
Principal Plans \| International bonds \| Net Asset Value or Its Equivalent
Fair value of plan assets	549	1,144
Principal Plans \| International bonds \| Fair Value, Inputs, Level 2
Fair value of plan assets	33	43
Principal Plans \| U.S. Equity
Fair value of plan assets		17
Principal Plans \| U.S. Equity \| Fair Value, Inputs, Level 1
Fair value of plan assets		17
Principal Plans \| International Equity
Fair value of plan assets		32
Principal Plans \| International Equity \| Fair Value, Inputs, Level 1
Fair value of plan assets		32
Principal Plans \| Non-U.S. Equity \| Net Asset Value or Its Equivalent
Fair value of plan assets		46
Principal Plans \| Global equity
Fair value of plan assets	221
Principal Plans \| Global equity \| Net Asset Value or Its Equivalent
Fair value of plan assets		423
Principal Plans \| Insurance Contract
Fair value of plan assets	222	355
Principal Plans \| Insurance Contract \| Fair Value, Inputs, Level 3
Fair value of plan assets	222	355
Principal Plans \| Other
Fair value of plan assets	(1)	(1)
Principal Plans \| Other \| Fair Value, Inputs, Level 1
Fair value of plan assets	(1)	1
Principal Plans \| Defined Benefit Plan, Equity Securities, Non-US
Fair value of plan assets	15
Principal Plans \| Defined Benefit Plan, Equity Securities, Non-US \| Fair Value, Inputs, Level 1
Fair value of plan assets	15
Principal Plans \| Defined Benefit Plan, Equity Securities, US
Fair value of plan assets	21
Principal Plans \| Defined Benefit Plan, Equity Securities, US \| Fair Value, Inputs, Level 1
Fair value of plan assets	21
Defined Benefit Pension Plans
Fair value of plan assets	$ 2,321	$ 3,744	$ 4,193

Employee Postretirement Bene_11

Employee Postretirement Benefits (Gross Benefit Payments) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Defined Benefit Pension Plans
2020	$ 179
2021	190
2022	188
2023	189
2024	192
2025-2029	929
Other Postretirement Benefit Plans
2020	57
2021	58
2022	57
2023	56
2024	53
2025-2029	$ 233

Stockholders' Equity (Narrative

Stockholders' Equity (Narratives) (Details) $ in Millions	12 Months Ended
Stockholders' Equity (Narratives) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Components of AOCI
Unrecognized net actuarial loss	$ 735
Unrecognized net prior service credit	$ 2

Stockholders' Equity Components

Stockholders' Equity Components of AOCI attributable to Kimberly-Clark, net of tax (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		$ (3,239)
Net current period other comprehensive income (loss)		(437)	$ (82)	$ 132
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		(3,669)	(3,239)
Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
Defined benefit and Other postretirement benefit plans, tax effect		(1)	(36)	(20)
Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss)
Defined benefit and Other postretirement benefit plans, tax effect		(27)	(6)	8
Unrealized Translation
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		(2,422)	(2,157)
Other comprehensive income (loss) before reclassifications		(347)	(265)
(Income) loss reclassified from AOCI		0	0
Net current period other comprehensive income (loss)		(347)	(265)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		(2,769)	(2,422)	(2,157)
Defined Benefit Pension Plans and Other Postretirement Benefit Plans \| Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		(803)	(912)
Other comprehensive income (loss) before reclassifications		(51)	37
(Income) loss reclassified from AOCI	[1]	65	72
Net current period other comprehensive income (loss)		14	109
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		(789)	(803)	(912)
Defined Benefit Pension Plans and Other Postretirement Benefit Plans \| Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		(34)	(40)
Other comprehensive income (loss) before reclassifications		86	9
(Income) loss reclassified from AOCI	[1]	0	(3)
Net current period other comprehensive income (loss)		86	6
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		52	(34)	(40)
Cash Flow Hedges and Other
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		20	(63)
Other comprehensive income (loss) before reclassifications		(139)	53
(Income) loss reclassified from AOCI		(44)	30
Net current period other comprehensive income (loss)		(183)	83
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		(163)	20	(63)
Kimberly-Clark Corporation
Accumulated Other Comprehensive Income (Loss)
Unrealized translation, tax effect		(23)	(17)	16
Unrealized translation, tax effect		$ (23)	$ (17)	$ 16

[1]Included in computation of net periodic pension and other postretirement benefits costs (see Note 8).

Stockholders' Equity Componen_2

Stockholders' Equity Components of Stockholders' Equity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss)
Unrealized translation	$ (355)	$ (288)	$ 129
Recognition of effective portion of hedges	(165)	70	(32)
Change in AOCI	(430)	(67)	122
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	(183)	83	(32)
Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
Defined benefit and Other postretirement benefit plans, tax effect	(1)	(36)	(20)
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax	14	109	67
Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss)
Defined benefit and Other postretirement benefit plans, tax effect	(27)	(6)	8
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax	86	6	(27)
Kimberly-Clark Corporation
Accumulated Other Comprehensive Income (Loss)
Unrealized translation, before tax	(324)	(248)	98
Unrealized translation, tax effect	(23)	(17)	16
Unrealized translation	(347)	(265)	114
Unrecognized net actuarial loss and transition amount \| Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
Funded status recognition, Defined benefit pension plans	(109)	16	24
Amortization, Defined benefit pension plans	34	37	41
Settlements and curtailments	52	91	49
Currency and other	(36)	(10)	26
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension Plans, before Tax	13	154	88
Unrecognized net actuarial loss and transition amount \| Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss)
Unrecognized net actuarial loss and transition amount and other	113	12	(35)
Unrecognized prior service cost/credit \| Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
Settlements and curtailments	0	(3)	0
Amortization, Unrecognized prior service cost/credit	0	(4)	(4)
Currency and other	0	0	(1)
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension Plans, before Tax	2	(9)	(1)
Funded status recognition, Unrecognized prior service cost/credit	(2)	2	(2)
Cash Flow Hedges and Other
Accumulated Other Comprehensive Income (Loss)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax	62	(22)	7
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss)
Currency and other	(22)	(4)	(5)
Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net	$ 58	$ (39)	$ 2

Leases and Commitments (Narrati

Leases and Commitments (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Leases and Commitments
Lessee Operating Leases Remaining Contractual Terms	96 years
Operating Leases, Options To Extend Lease Terms	99
Operating, Options To Terminate Lease Term	1
Operating Lease, Weighted Average Remaining Lease Term	5 years
Operating Lease, Weighted Average Discount Rate, Percent	3%
Long-Term Contracts, Purchase Obligations Due in 2020	$ 1,794
Long-Term Contracts, Purchase Obligations Due in 2022	798
Long-Term Contracts, Purchase Obligations Due in 2023	279
Long-Term Contracts, Purchase Obligations Due in 2024	252
Long-Term Contracts, Purchase Obligations Due Beyond 2024	39
Long-Term Contracts, Purchase Obligations Due in 2021	958
Finance Lease, Right-of-Use Asset, Accumulated Amortization	$ 32	$ 27
Finance Lease, Weighted Average Remaining Lease Term	8 years
Finance Lease, Weighted Average Discount Rate, Percent	3%

Leases and Commitments Operatin

Leases and Commitments Operating Lease Cost (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finance Lease, Cost	$ 16	$ 15	$ 10
Lease, Cost	403	391	380
Cost of Products Sold, Marketing, Research and General Expense
Operating Lease, Cost	145	157	168
Variable Lease, Cost	242	219	202
Cost of Sales
Finance Lease, Right-of-Use Asset, Amortization	15	13	9
Interest Expense
Finance Lease, Interest Expense	$ 1	$ 2	$ 1

Leases and Commitments Operat_2

Leases and Commitments Operating Lease Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Lease, Right-Of-Use Asset	$ 546	$ 574
Lease, Right-Of-Use Asset	546	574
Other Liabilities [Member]
Leases [Abstract]
Lease, Liability	564	594
Lease, Liability	$ 564	$ 594
Long-term Debt [Member]
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Long-Term Debt	Long-Term Debt
Property, Plant and Equipment
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, Plant and Equipment, Net
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$ 71	$ 86
Other Current Liabilities
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Current	Other Liabilities, Current
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Debt payable within one year	Debt payable within one year
Other Noncurrent Liabilities
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Other Noncurrent Assets
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets	Other Assets

Leases and Commitments Maturity

Leases and Commitments Maturity of Operating Lease Liabilities (Details) $ in Millions	Dec. 31, 2022 USD ($)
Leases [Abstract]
Lessee, Operating Lease, Liability, Payments, Due Year One	$ 138
Lessee, Operating Lease, Liability, Payments, Due Year Two	119
Operating Leases, Future Minimum Payments, Due in Three Years	100
Operating Leases, Future Minimum Payments, Due in Four Years	83
Operating Leases, Future Minimum Payments, Due in Five Years	53
Operating Leases, Future Minimum Payments, Due Thereafter	46
Lessee, Operating Lease, Liability, Payments, Due	539
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	35
Finance Lease, Liability, to be Paid, Year One	13
Lessee Operating and Financing Lease Liability To Be Paid Year One	151
Lessee Operating and Financing Lease Liability To Be Paid Year Two	129
Finance Lease, Liability, to be Paid, Year Two	10
Lessee Operating and Financing Lease Liability To Be Paid Year Three	108
Finance Lease, Liability, to be Paid, Year Three	8
Lessee Operating and Financing Lease Liability To Be Paid Year Four	89
Finance Lease, Liability, to be Paid, Year Four	6
Lessee Operating and Financing Lease Liability To Be Paid Year Five	58
Finance Lease, Liability, to be Paid, Year Five	5
Lessee Operating and Financing Lease Liability To Be Paid After Year Five	73
Finance Lease, Liability, to be Paid, after Year Five	27
Lessee Operating and Financing Lease Liability Payments Due	608
Finance Lease, Liability, Payment, Due	69
Finance Lease, Liability, Undiscounted Excess Amount	9
Lessee Operating and Financing Lease Liability Undiscounted Excess Amount	44
Finance Lease, Liability	60
Operating and Finance Lease Liability	564
Other Liabilities [Member]
Leases [Abstract]
Operating Lease, Liability	504
Operating Lease, Liability	$ 504

Supplemental Information Relate

Supplemental Information Related Operating Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating Lease, Payments	$ 148	$ 155	$ 164
Finance Lease, Principal Payments	11	13	14
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	57	34	198
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	6	56	20
Right of Use Asset Obtained in Exchange for Operating Lease Liability Modifications	$ 72	$ 61	$ 98

Objectives and Strategies for_2

Objectives and Strategies for Using Derivatives (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax	$ 72
Foreign Exchange Contract \| Not Designated as Hedging Instrument
Aggregate notional value	2,200
Gains (Losses) on undesignated foreign exchange hedging instruments	(29)	$ (5)	$ 39
Fair Value, Measurements, Recurring \| Fair Value, Inputs, Level 2
Derivative Assets	99	65
Derivative Liability	318	41
Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag	99	65
Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag	318	$ 41
Net Investment Hedging \| Foreign Exchange Contract
Aggregate notional value	1,300
Fair Value Hedging \| Interest Rate Contract
Aggregate notional value	525
Long-term Debt, Fair Value	470
Cash Flow Hedging \| Foreign Exchange Contract
Aggregate notional value	$ 2,500

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes
Provision for income taxes	$ 495	$ 479	$ 676
Undistributed earnings of foreign subsidiaries expected to be repatriated	101	105
Undistributed earnings of foreign subsidiaries	7,400
Operating Loss Carryforwards, Valuation Allowance	1,200
Income tax loss carryforwards, subject to expiration	534
Remaining amount of loss carryforwards that has no expiration date	687
Unrecognized tax benefits that would reduce our effective tax rate if recognized	420
Total accrued penalties and net accrued interest	35	$ 24
Aggregate resolution of uncertainties	130
U.S. Tax Cuts and Jobs Act
Income Taxes
Undistributed earnings of foreign subsidiaries expected to be repatriated	700
Undistributed earnings of foreign subsidiaries	3,700
Undistributed earnings of foreign subsidiaries considered indefinitely reinvested	3,000
Brazil Tax Matter [Member]
Income Taxes
Proposed Tax Adjustments and Penalties, Foreign Tax Authority	$ 60

Income Taxes (Analysis of the P

Income Taxes (Analysis of the Provision for Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
United States	$ 248	$ 179	$ 252
State	16	35	81
Other countries	288	335	298
Total	552	549	631
United States	(27)	(18)	62
State	(1)	(1)	5
Other countries	(29)	(51)	(22)
Total	(57)	(70)	45
Total provision for income taxes	$ 495	$ 479	$ 676

Income Taxes (Income before Inc

Income Taxes (Income before Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
United States	$ 1,802	$ 1,580	$ 2,336
Other countries	538	645	594
Total income before income taxes	$ 2,340	$ 2,225	$ 2,930

Income Taxes (Deferred Income T

Income Taxes (Deferred Income Tax Assets (Liabilities)) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Pension and other postretirement benefits	$ 179	$ 215
Tax credits and loss carryforwards	534	531
Deferred Tax Assets, Capitalized Research Costs	118	0
Lease liability	116	116
Deferred tax assets, prepaid royalties	56	117
Deferred Tax Assets, Derivatives	74	38
Other	353	317
Deferred Tax Assets, Gross	1,430	1,334
Valuation allowances	(299)	(279)
Total deferred tax assets	1,131	1,055
Property, plant and equipment, net	940	921
Investments in subsidiaries	101	105
Deferred Tax Liabilities, Intangible Assets	153	156
Lease asset	111	114
Other	229	228
Total deferred tax liabilities	1,534	1,524
Net deferred tax assets (liabilities)	$ (403)	$ (469)

Income Taxes (Reconciliation of

Income Taxes (Reconciliation of Income Tax Provision) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes
U.S. statutory rate applied to income before income taxes and equity interests		21%	21%	21%
State income taxes, net of federal tax benefit		0.50%	1.20%	2.30%
Routine tax incentives		(3.50%)	(5.80%)	(4.30%)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent		1.40%	1.50%	0.80%
Statutory rates other than U.S. statutory rate		2.40%	2.40%	2.70%
Valuation allowance		1.30%	2.40%	0.70%
Other - net	[1]	(1.90%)	(1.20%)	(0.10%)
Effective income tax rate		21.20%	21.50%	23.10%
Deferred tax assets, prepaid royalties		$ 56	$ 117

[1]Other - net is composed of numerous items, none of which is greater than 1.05 percent of income before income taxes and equity interests.

Income Taxes (Unrecognized Inco

Income Taxes (Unrecognized Income Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns
Balance at January 1	$ 506	$ 497	$ 383
Gross increases for tax positions of prior years	22	62	144
Gross decreases for tax positions of prior years	(38)	(37)	(34)
Gross increases for tax positions of the current year	36	42	36
Settlements	(21)	(39)	(22)
Other	(17)	(19)	(10)
Balance at December 31	$ 488	$ 506	$ 497

Income Taxes (Summary of Income

Income Taxes (Summary of Income Tax Examinations) (Details)	12 Months Ended
Income Taxes (Summary of Income Tax Examinations) (Details)	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Summary of Income Tax Examinations	As of December 31, 2022, the following tax years remain subject to examination for the major jurisdictions where we conduct business: Jurisdiction Years United States 2016 to 2022 United Kingdom 2020 to 2022 Brazil 2016 to 2022 China 2011 to 2022 South Korea 2020 to 2022
Minimum \| United States \| Domestic Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2016
Minimum \| United Kingdom \| Foreign Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2020
Minimum \| Brazil \| Foreign Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2016
Minimum \| China \| Foreign Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2011
Minimum \| Korea (South), Won \| Foreign Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2020
Maximum \| United States \| Domestic Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2022
Maximum \| United Kingdom \| Foreign Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2022
Maximum \| Brazil \| Foreign Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2022
Maximum \| China \| Foreign Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2022
Maximum \| Korea (South), Won \| Foreign Tax Authority
Income Tax Examination
Income Tax Examination, Year under Examination	2022

Earnings Per Share (Narratives)

Earnings Per Share (Narratives) (Details) - shares shares in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Common shares outstanding	337.5	336.8	338.7

Earnings Per Share (Average Com

Earnings Per Share (Average Common shares Outstanding Basic and Diluted) (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Basic	337.4	337.3	340.7
Dilutive effect of stock options and restricted share unit awards	0.9	1.5	1.8
Diluted	338.3	338.8	342.5

Business Segment and Geograph_2

Business Segment and Geographic Data Information (Narrative) (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net Sales Percentage to One Customer \| Customer Concentration Risk \| Walmart Inc.
Net sales to Walmart, percent	13%	14%	15%

Business Segment and Geograph_3

Business Segment and Geographic Data Information (Information Concerning Consolidated Operations by Business Segment) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Revenues	[1]	$ 20,175		$ 19,440		$ 19,140
Depreciation and amortization		754		766		796
Operating Profit		2,681		2,561		3,244
Other (income) expense, net	[2]	(43)		28		(54)
Capital Spending		876		1,007		1,217
Assets		17,970		17,837		17,523
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain		(85)		0		0
Softex Indonesia [Member]
Business Acquisition, Transaction Costs						32
Thinx, Inc.
Business Combination, Acquisition Related Costs		21
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain		(85)
United States
Revenues		9,848		9,285		9,679
Personal Care
Revenues		10,622	[1]	10,267	[1]	9,339
Depreciation and amortization		375		355		347
Operating Profit	[3]	1,787		1,856		1,933
Capital Spending		442		536		616
Assets		9,086		8,890		8,486
Consumer Tissue
Revenues	[1]	6,243		6,034		6,718
Depreciation and amortization		251		291		334
Operating Profit	[3]	806		888		1,448
Capital Spending		280		303		391
Assets		5,048		5,083		5,227
K-C Professional and Other
Revenues	[1]	3,256		3,072		3,019
Depreciation and amortization		125		116		111
Operating Profit	[3]	457		404		528
Capital Spending		142		157		204
Assets		2,675		2,650		2,551
Corporate and Other
Revenues	[1]	54		67		64
Depreciation and amortization		3		4		4
Operating Profit	[4]	(412)		(559)		(719)
Capital Spending		12		11		6
Assets		1,161		1,214		1,259
Corporate and Other \| Softex Indonesia [Member]
Business Acquisition, Transaction Costs		$ 32
2018 Global Restructuring Program \| Personal Care
Restructuring Charges				104		156
2018 Global Restructuring Program \| Consumer Tissue
Restructuring Charges				118		176
2018 Global Restructuring Program \| K-C Professional and Other
Restructuring Charges				40		53
Other Income
Business tax credit, favorable legal ruling, foreign						77
Corporate and Other \| 2018 Global Restructuring Program
Restructuring Charges				$ 265		$ 392

[1] Net sales in the U.S. to third parties totaled $9,848, $9,285 and $9,679 in 2022, 2021 and 2020, respectively. No other individual country's net sales exceeds 10 percent of total net sales.

Business Segment and Geograph_4

Business Segment and Geographic Data Information (Sales of Principal Products) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues	[1]	$ 20,175	$ 19,440	$ 19,140
Baby and Child Care Products
Revenues		7,200	7,200	6,400
Consumer Tissue Products
Revenues		6,200	6,000	6,700
Away from Home Professional Products
Revenues		3,300	3,100	3,000
All Other
Revenues		$ 3,500	$ 3,100	$ 3,000

[1] Net sales in the U.S. to third parties totaled $9,848, $9,285 and $9,679 in 2022, 2021 and 2020, respectively. No other individual country's net sales exceeds 10 percent of total net sales.

Supplemental Data (Narrative) (

Supplemental Data (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Supplemental Data
Investments in Equity Companies	$ 238	$ 290
Retained Earnings, Undistributed Earnings from Equity Method Investees	1,100
Property, Plant and Equipment, Net	7,885	8,097
United States
Supplemental Data
Property, Plant and Equipment, Net	$ 4,273	$ 4,165
Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries
Supplemental Data
Equity Method Investment, Ownership Percentage	47.90%
Investments in Equity Companies	$ 179
Equity Method Investments, Fair Value Disclosure	$ 2,700

Supplemental Data (Supplemental

Supplemental Data (Supplemental Income Statement Data) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Supplemental Data
Advertising expense	$ 901	$ 893	$ 956
Research expense	$ 292	$ 269	$ 276

Supplemental Data Supplemental

Supplemental Data Supplemental Data (Equity Method Investment Data) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Profit		$ 438	$ 398	$ 507
Corporation's Share of Net Income		116	98	142
Revenues	[1]	20,175	19,440	19,140
Gross Profit		6,219	5,988	6,822
Net Income (Loss) Attributable to Parent		1,934	1,814	2,352
Stockholders' Equity Attributable to Parent		547	514
Liabilities, Current		7,334	6,749
Assets, Current		5,729	5,565
Equity Method Investment, Summarized Financial Information, Revenue
Revenues		2,690	2,501	2,358
Equity Method Investment, Summarized Financial Information, Gross Profit
Gross Profit		707	696	786
Equity Method Investments, Summarized Financial Information, Net Income
Net Income (Loss) Attributable to Parent		240	205	299
Equity Method Investment, Summarized Financial Information, Current Assets
Assets, Current		1,585	1,283	1,585
Equity Method Investment, Summarized Financial Information, Noncurrent Assets
Assets, Noncurrent		1,303	1,219	1,203
Equity Method Investments, Summarized Financial Information, Current Liabilities
Liabilities, Current		814	809	842
Equity Method Investment, Summarized Financial Information, Noncurrent Liabilities
Liabilities, Noncurrent		1,751	1,334	1,563
Equity Method Investments, Summarized Financial Information, Stockholders' Equity
Stockholders' Equity Attributable to Parent		$ 323	$ 360	$ 382

[1] Net sales in the U.S. to third parties totaled $9,848, $9,285 and $9,679 in 2022, 2021 and 2020, respectively. No other individual country's net sales exceeds 10 percent of total net sales.

Supplemental Data (Summary of A

Supplemental Data (Summary of Accounts Receivable, Net) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Supplemental Data (Millions of dollars) [Abstract]
From customers	$ 2,155	$ 2,092
Other	189	170
Less allowance for doubtful accounts and sales discounts	(64)	(55)
Total	$ 2,280	$ 2,207

Supplemental Data (Summary of I

Supplemental Data (Summary of Inventories) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Inventory
Raw materials	$ 572	$ 493
Work in process	246	242
Finished goods	1,388	1,442
Supplies and other	302	280
Gross inventories	2,508	2,457
Excess of FIFO or weighted-average cost over LIFO cost	(239)	(218)
Total	2,269	2,239
LIFO
Inventory
Raw materials	147	141
Work in process	139	153
Finished goods	518	607
Supplies and other	0	0
Gross inventories	804	901
Excess of FIFO or weighted-average cost over LIFO cost	(239)	(218)
Total	565	683
Non- LIFO
Inventory
Raw materials	425	352
Work in process	107	89
Finished goods	870	835
Supplies and other	302	280
Gross inventories	1,704	1,556
Excess of FIFO or weighted-average cost over LIFO cost	0	0
Total	$ 1,704	$ 1,556

Supplemental Data (Summary of P

Supplemental Data (Summary of Property, Plant and Equipment, Net) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Supplemental Data
Land	$ 156	$ 169
Buildings	3,062	2,993
Machinery and equipment	14,655	14,606
Construction in progress	676	760
Total before accumulated depreciation	18,549	18,528
Less accumulated depreciation	(10,664)	(10,431)
Total	$ 7,885	$ 8,097

Supplemental Data (Summary of_2

Supplemental Data (Summary of Accrued Expenses) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Supplemental Data
Accrued advertising and promotion	$ 455	$ 434
Accrued salaries and wages	421	403
Accrued rebates	285	249
Accrued taxes - income and other	318	323
Accrued restructuring	0	75
Accrued interest	82	85
Derivative Liability, Current	200	23
Other	401	374
Total	2,289	2,096
Other Current Liabilities
Supplemental Data
Operating lease	127	130
Operating lease	$ 127	$ 130

Supplemental Data (Summary of C

Supplemental Data (Summary of Cash Flow Effects of Decrease (Increase) in Operating Working Capital) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounts receivable	$ (151)	$ (37)	$ 95
Inventories	(76)	(417)	(96)
Trade accounts payable	109	627	239
Accrued expenses	92	(124)	132
Accrued income taxes	20	(4)	42
Derivatives	9	30	(9)
Currency and other	(20)	(29)	(40)
Total	$ (17)	$ 46	$ 363

Supplemental Data (Other Cash F

Supplemental Data (Other Cash Flow Data and Interest Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Supplemental Data
Income Taxes Paid	$ 468	$ 492	$ 533
Interest Paid, Including Capitalized Interest, Operating and Investing Activities	$ 270	$ 243	$ 245

Valuation and Qualifying Acco_2

Valuation and Qualifying Accounts (Schedule of Valuation and Qualifying Accounts) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Allowance for Doubtful Accounts
Movement in Valuation Allowances and Reserves
Balance at Beginning of Period		$ 40	$ 34	$ 32
Charged to Costs and Expenses		14	12	3
Charged to Other Accounts	[1]	(3)	(4)	1
Deductions	[2]	4	2	2
Balance at End of Period		47	40	34
Allowances for Sales Discounts
Movement in Valuation Allowances and Reserves
Balance at Beginning of Period		15	16	17
Charged to Costs and Expenses		239	225	240
Charged to Other Accounts	[1]	(3)	(2)	(3)
Deductions	[3]	234	224	238
Balance at End of Period		17	15	16
Deferred Taxes
Movement in Valuation Allowances and Reserves
Balance at Beginning of Period		279	272	248
Charged to Costs and Expenses		37	12	21
Charged to Other Accounts		0	0	0
Deductions	[4]	17	5	(3)
Balance at End of Period		$ 299	$ 279	$ 272

[1]Includes bad debt recoveries and the effects of changes in foreign currency exchange rates.[2]Primarily uncollectible receivables written off.[3]Sales discounts allowed.[4]Represents the net currency effects of translating valuation allowances at current rates of exchange.

Uncategorized Items - kmb-20221

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 442,000,000